ý
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the Fiscal Year Ended December 31, 2018
|
OR
|
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the Transition Period From to
|
|
Delaware
|
47-0937650
|
(State or Other Jurisdiction
|
(I.R.S. Employer
|
of Incorporation or Organization)
|
Identification No.)
|
|
|
8735 Henderson Road, Renaissance One
|
|
Tampa, Florida
|
33634
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Common Stock, par value $0.01 per share
|
New York Stock Exchange
|
(Title of Class)
|
(Name of Each Exchange on which Registered)
|
|
Page
|
PART I
|
|
Item 1: Business
|
|
Item 1A: Risk Factors
|
|
Item 1B: Unresolved Staff Comments
|
|
Item 2: Properties
|
|
Item 3: Legal Proceedings
|
|
Item 4: Mine Safety Disclosures
|
|
|
|
PART II
|
|
Item 5: Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
|
|
Item 6: Selected Financial Data
|
|
Item 7: Management's Discussion and Analysis of Financial Condition and Results of Operations
|
|
Item 7A: Qualitative and Quantitative Disclosures About Market Risk
|
|
Item 8: Financial Statements and Supplementary Data
|
|
Item 9: Changes In and Disagreements With Accountants on Accounting and Financial Disclosure
|
|
Item 9A: Controls and Procedures
|
|
Item 9B: Other Information
|
|
|
|
PART III
|
|
Item 10: Directors, Executive Officers and Corporate Governance
|
|
Item 11: Executive Compensation
|
|
Item 12: Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
|
|
Item 13: Certain Relationships and Related Transactions, and Director Independence
|
|
Item 14: Principal Accounting Fees and Services
|
|
|
|
PART IV
|
|
Item 15: Exhibits, Financial Statement Schedules
|
|
Medicaid
|
|
Medicare
|
|
Medicare
|
|
Total Membership
|
|
Percent of Total Membership
|
|||||
State
|
Health Plans
(2)
|
|
Health Plans
(2)
|
|
PDPs
|
|
|
|||||||
Illinois
|
842,000
|
|
|
27,000
|
|
|
35,000
|
|
|
904,000
|
|
|
16.3
|
%
|
Florida
|
777,000
|
|
|
96,000
|
|
|
29,000
|
|
|
902,000
|
|
|
16.3
|
%
|
Georgia
|
493,000
|
|
|
51,000
|
|
|
15,000
|
|
|
559,000
|
|
|
10.1
|
%
|
Michigan
|
500,000
|
|
|
19,000
|
|
|
44,000
|
|
|
563,000
|
|
|
10.2
|
%
|
Kentucky
|
444,000
|
|
|
14,000
|
|
|
22,000
|
|
|
480,000
|
|
|
8.7
|
%
|
New York
|
155,000
|
|
|
88,000
|
|
|
52,000
|
|
|
295,000
|
|
|
5.3
|
%
|
Other states
(1)
|
720,000
|
|
|
250,000
|
|
|
860,000
|
|
|
1,830,000
|
|
|
33.0
|
%
|
Health Insurance Marketplace
(3)
|
—
|
|
|
—
|
|
|
—
|
|
|
5,000
|
|
|
0.1
|
%
|
Total
|
3,931,000
|
|
|
545,000
|
|
|
1,057,000
|
|
|
5,538,000
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Represents the aggregate of all states that individually have less than 5% of total membership.
|
(2)
|
Medicaid Health Plans and Medicare Health Plans membership includes members who are dually-eligible and participate in both our Medicaid and Medicare programs. The dually-eligible membership was
68,000
at
December 31, 2018
.
|
(3)
|
Health Insurance Marketplace, included in our Corporate and Other category as it does not meet the quantification thresholds required by generally accepted accounting principles and therefore not individually reportable, includes members from Michigan. Total Michigan membership is
568,000
members.
|
•
|
we must coordinate care that encompasses the full breadth of a member's needs including their physical health, behavioral health, pharmacy, LTSS and, increasingly, their need for social, non-medical services;
|
•
|
we contract with providers and measure access and availability in terms of the time needed for a member to reach the doctor's office;
|
•
|
our quality improvement programs must emphasize member education, member outreach and include measures designed to promote utilization of preventive services;
|
•
|
we must have linkages with schools, city or county health departments and other community-based providers of health care in order to demonstrate our ability to coordinate all of the sources from which our members may receive care;
|
•
|
we must have the capability to meet the needs of members with complex conditions including those with co-occurring conditions and those who have disabilities;
|
•
|
our providers and member service representatives must be able to communicate with members who do not speak English or who are hearing impaired;
|
•
|
our member handbook, newsletters and other communications must be written at the prescribed reading level and must be available in certain languages other than English;
|
•
|
we must have the capabilities to meet any specialized waiver requirements, such as member premium payments or work eligibility requirements; and
|
•
|
we must demonstrate our readiness to meet contract requirements prior to the commencement date of services.
|
|
For the Years Ended December 31,
|
||||||||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||||||||
Segment
|
Membership
|
|
Percentage of Total
|
|
Membership
|
|
Percentage of Total
|
|
Membership
|
|
Percentage of Total
|
||||||
Medicaid Health Plans
|
3,931,000
|
|
|
71.0
|
%
|
|
2,723,000
|
|
|
62.3
|
%
|
|
2,544,000
|
|
|
65.3
|
%
|
Medicare Health Plans
|
545,000
|
|
|
9.8
|
%
|
|
496,000
|
|
|
11.3
|
%
|
|
345,000
|
|
|
8.9
|
%
|
Medicare PDPs
|
1,057,000
|
|
|
19.1
|
%
|
|
1,152,000
|
|
|
26.4
|
%
|
|
1,009,000
|
|
|
25.8
|
%
|
Corporate and Other
|
5,000
|
|
|
0.1
|
%
|
|
—
|
|
|
—
|
%
|
|
—
|
|
|
—
|
%
|
Total
|
5,538,000
|
|
|
100.0
|
%
|
|
4,371,000
|
|
|
100.0
|
%
|
|
3,898,000
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
State
|
|
Line of Business
|
|
Term of Contract
|
Florida
|
|
Medicaid (MMA)
|
|
February 4, 2014 - December 31, 2018
|
Florida
|
|
Medicaid and LTC
|
|
August 27, 2018 - December 31, 2023
|
Kentucky
|
|
Medicaid and CHIP
|
|
July 1, 2018 - June 30, 2019
|
|
As of December 31,
|
|||||||
|
2018
|
|
2017
|
|
2016
|
|||
Medicaid Health Plans
|
|
|
|
|
|
|||
TANF
|
3,322,000
|
|
|
2,278,000
|
|
|
2,119,000
|
|
SSI, ABD, duals, and LTSS
|
442,000
|
|
|
301,000
|
|
|
290,000
|
|
CHIP and other
|
167,000
|
|
|
144,000
|
|
|
135,000
|
|
Total
|
3,931,000
|
|
|
2,723,000
|
|
|
2,544,000
|
|
|
|
|
|
|
|
|
As of December 31,
|
|||||||
|
2018
|
|
2017
|
|
2016
|
|||
Medicaid Health Plans
|
|
|
|
|
|
|||
Illinois
|
842,000
|
|
|
138,000
|
|
|
166,000
|
|
Florida
|
777,000
|
|
|
751,000
|
|
|
780,000
|
|
Michigan
|
500,000
|
|
|
—
|
|
|
—
|
|
Georgia
|
493,000
|
|
|
513,000
|
|
|
571,000
|
|
Kentucky
|
444,000
|
|
|
448,000
|
|
|
440,000
|
|
All other states
(1)
|
875,000
|
|
|
873,000
|
|
|
587,000
|
|
Total
|
3,931,000
|
|
|
2,723,000
|
|
|
2,544,000
|
|
|
|
|
|
|
|
(1)
|
"All other states" consists of Arizona, Hawaii, Missouri, New Jersey, New York, South Carolina and Texas during all years presented. In 2017 and 2018, it also includes Nebraska.
|
•
|
execution on quality and affordability initiatives;
|
•
|
continued application of a disciplined portfolio approach to our MA bids, including a focus on net income; and
|
•
|
improving Star Ratings, both in terms of execution on quality initiatives and our advocacy position to properly match the ratings, rules and economics with the prevalent data that demonstrates the connection between socio-economic status and lower quality ratings.
|
•
|
Professionals
such as PCPs, provider groups, specialty care physicians, psychologists and licensed social workers;
|
•
|
Facilities
such as hospitals with inpatient, outpatient and emergency services, skilled nursing facilities, outpatient surgical facilities, urgent care facilities/clinics, Federally Qualified Health Centers ("FQHC") and diagnostic imaging centers;
|
•
|
Ancillary providers
such as laboratory providers, radiology, home health, physical therapy, speech therapy, occupational therapy, ambulance providers and transportation providers; and
|
•
|
Pharmacies,
including retail pharmacies, mail order pharmacies and specialty pharmacies.
|
•
|
Access;
|
•
|
Preventive health and wellness;
|
•
|
Care management and population health programs;
|
•
|
Health plan accreditation;
|
•
|
Provider credentialing;
|
•
|
Provider education and incentives for closing care gaps;
|
•
|
Member education and outreach;
|
•
|
Information technology initiatives related to the above activities;
|
•
|
Community Connections; and
|
•
|
Oversight and audits.
|
•
|
MCOs—
Managed care organizations ("MCOs") that, like us, receive state funding to provide Medicaid benefits to members. Many of these competitors operate in a single or small number of geographic locations. There are a few multi-state Medicaid organizations that are able to leverage their infrastructure over a larger membership base. Competitors include private and public companies, which can be either for-profit or non-profit organizations, with varying degrees of focus on serving Medicaid populations.
|
•
|
Medicaid Fee-For-Service—
Traditional Medicaid offered directly by the states or a modified version whereby the state administers a primary care case management model.
|
•
|
PSNs—
A Provider Service Network ("PSN") is a network of providers that is established and operated by a health care provider or group of affiliated health care providers. A PSN operates as either a fee-for-service ("FFS") health plan or
|
•
|
Original Fee-For-Service Medicare—
Original Medicare is available nationally and is a fee-for-service plan managed by the federal government. Beneficiaries enrolled in Original Medicare can go to any doctor, supplier, hospital or other facility that accepts Medicare and is accepting new Medicare patients.
|
•
|
Medicare Advantage and Prescription Drug Plans—
MA and stand-alone Part D plans are offered by national, regional and local MCOs and insurance companies that serve Medicare beneficiaries. In addition, prescription drug plans are being offered by or co-branded with retail drug store chains or other retail store chains, which may be able to offer lower priced plans and achieve benefits from integration with their pharmacy benefit management operations.
|
•
|
Employer-Sponsored Coverage—
Employers and unions may subsidize Medicare benefits for their retirees in their commercial group. The group sponsor solicits proposals from MA plans and may select an HMO, preferred provider organization ("PPO") and/or PDP to provide these benefits.
|
•
|
Accountable Care Organizations
- Accountable Care Organizations are groups of doctors, hospitals, and other health care providers who come together voluntarily to provide coordinated high quality care to their patients. The goal of coordinated care is to ensure that patients, especially the chronically ill, get the right care at the right time, while avoiding unnecessary duplication of services and preventing medical errors.
|
•
|
protect patient privacy and safeguard individually identifiable health information; and
|
•
|
establish the capability to receive and transmit electronically certain administrative health care transactions, such as claims payments, in a standardized format.
|
•
|
reducing the federal matching payments to state Medicaid and CHIP programs;
|
•
|
restricting revenue, enrollment and premium growth in certain products and market segments;
|
•
|
restricting our ability to expand into new markets;
|
•
|
increasing our medical and administrative costs;
|
•
|
lowering our Medicare payment rates and/or increasing our expenses associated with the non-deductible federal premium tax and other assessments;
|
•
|
encouraging states to contract with organizations that are not subject to the annual premium-based health insurance industry assessment imposed by the ACA (the "ACA industry fee") for their Medicaid programs; and
|
•
|
encouraging states to integrate Medicare and Medicaid using a limited number of health plans or a fee for service model.
|
•
|
the market price of our common stock could decline;
|
•
|
time and resources committed by our management to matters relating to the acquisition could otherwise have been devoted to pursuing other beneficial opportunities;
|
•
|
we may experience negative reactions from the financial markets or from our customers or employees;
|
•
|
we will be required to pay our costs relating to the acquisition, such as termination fees and legal, accounting and financial advisory expenses; and
|
•
|
we could be subject to litigation related to any failure to complete the acquisition or related to any enforcement proceeding commenced against us to perform our obligations under the transaction agreement.
|
•
|
difficulty retaining legacy employees and/or attracting new employees because of potential uncertainty in our business relating to the business combination;
|
•
|
acquired provider networks that operate on different terms than our existing networks and whose contracts may need to be renegotiated;
|
•
|
existing members who decide to switch to another health care plan;
|
•
|
separate administrative and information technology systems; and
|
•
|
difficulties implementing our operations strategy to operate the acquired businesses profitably.
|
•
|
the time and costs associated with obtaining the necessary licenses and approvals to operate;
|
•
|
lower quality scores compared to our competitors;
|
•
|
loss of our right to participate in government-sponsored programs, including Medicaid and Medicare;
|
•
|
participation in fewer lines of business compared to our competitors;
|
•
|
our inability to develop a network of physicians, hospitals and other health care providers that meets our requirements and those of government regulators;
|
•
|
delays in the procurement, renewal or implementation of Medicaid or similar programs in new or existing states;
|
•
|
our ability to serve increased membership;
|
•
|
CMS or state contract provisions regarding quality measures, such as CMS Star Ratings;
|
•
|
loss of our ability to expand Medicaid and Medicare programs;
|
•
|
competition, which increases the cost of recruiting members;
|
•
|
the cost of providing health care services in those areas;
|
•
|
demographics and population density; and
|
•
|
applicable state regulations that, among other things, require the maintenance of minimum levels of capital and surplus.
|
•
|
the addition of new members, whether by acquisition, new enrollment, program startup or expansion (including geographic expansion), whose risk profiles are uncertain or unknown and for whom initiatives to manage their care take longer than expected;
|
•
|
an increase in the cost of health care services and supplies, including pharmaceuticals, whether as a result of the introduction of new products or technologies, inflation or otherwise;
|
•
|
the performance of our pharmaceutical benefit managers in managing pharmaceutical costs;
|
•
|
higher-than-expected utilization of health care services, including pharmaceuticals;
|
•
|
contractual provisions related to continuity of care for new members;
|
•
|
contractual provisions or regulatory requirements restricting the use and design of quality and affordability initiatives, including the ability to control the pharmaceutical formulary in Medicaid programs;
|
•
|
periodic renegotiation of hospital, physician and/or other provider contracts;
|
•
|
the occurrence of catastrophes, natural disasters, epidemics, pandemics, terrorism or bio-terrorism;
|
•
|
changes in the demographics of our members and medical trends affecting them;
|
•
|
challenges in implementing medical expense cost control initiatives, especially during the first year of a new Medicaid program or a new product;
|
•
|
new mandated benefits, increased mandated provider reimbursement rates or other changes in health care laws, regulations, public policy and/or practices;
|
•
|
emerging changes in the economy;
|
•
|
changes in members' behavior and health care utilization patterns;
|
•
|
provider billing practices; and
|
•
|
changes in the fee schedules, rate design, and reimbursement structure for health care services.
|
•
|
imposing additional license, accreditation, registration and/or capital requirements;
|
•
|
increasing our administrative and other costs;
|
•
|
requiring us to change our operating structure;
|
•
|
requiring significant additional reporting and technological capabilities;
|
•
|
imposing additional fees and taxes, which cannot be offset by increased premium revenue;
|
•
|
increasing mandated benefits, such as the proposed mental health parity regulation;
|
•
|
further limiting our ability to engage in intra-company transactions with our affiliates and subsidiaries;
|
•
|
restricting our revenue and enrollment growth;
|
•
|
requiring us to restructure our relationships with providers; and
|
•
|
requiring us to implement additional or different programs and systems.
|
•
|
claims by government agencies relating to compliance with laws and regulations;
|
•
|
claims relating to sales practices and member enrollment;
|
•
|
claims relating to the methodologies for calculating premiums;
|
•
|
claims relating to the denial or delay of health care benefit payments;
|
•
|
claims relating to claims payments and procedures;
|
•
|
claims relating to provider marketing;
|
•
|
claims by providers for network termination or exclusion;
|
•
|
anti-kickback claims;
|
•
|
medical malpractice or negligence actions based on our medical necessity decisions or brought against us on the theory that we are liable for our providers’ malpractice or negligence;
|
•
|
allegations of anti-competitive and unfair business activities;
|
•
|
provider disputes over compensation and termination of provider contracts or defamation claims;
|
•
|
allegations of discrimination;
|
•
|
allegations of breaches of duties;
|
•
|
claims relating to inadequate or incorrect disclosure or accounting in our public filings and other statements;
|
•
|
allegations of agent misconduct;
|
•
|
claims related to deceptive trade practices;
|
•
|
claims relating to audits and contract performance;
|
•
|
protests related to Medicaid awards; and
|
•
|
violations of state procurement laws and policies.
|
•
|
loss of our right to participate in government-sponsored programs, including Medicaid and Medicare;
|
•
|
forfeiture or recoupment of amounts we have been paid pursuant to our government contracts;
|
•
|
imposition of significant civil or criminal penalties, fines or other sanctions on us and/or our key associates;
|
•
|
reduction or limitation of our membership;
|
•
|
damage to our reputation in various markets;
|
•
|
increased difficulty in marketing our products and services;
|
•
|
inability to obtain approval for future acquisitions or service or geographic expansion;
|
•
|
suspension or loss of one or more of our licenses to act as an insurer, HMO, third party administrator, or pharmaceutical benefit manager or to otherwise provide a service; and
|
•
|
an event of default under our debt agreements.
|
•
|
limit our ability to borrow additional funds for working capital, capital expenditures, acquisitions and general corporate or other purposes; and
|
•
|
expose us to greater interest rate risk since the interest rate on borrowings under our Amended and Restated Credit Agreement is variable.
|
•
|
variations in our operating results;
|
•
|
changes in our or the market's expectations about our future operating results;
|
•
|
changes in financial estimates and recommendations by securities analysts concerning our Company or the health care industry generally;
|
•
|
operating and stock price performance of other companies that investors may deem comparable;
|
•
|
news reports relating to trends in our markets;
|
•
|
changes or proposed changes in the laws, regulations and policies affecting our business;
|
•
|
acquisitions and financings by us or others in our industry;
|
•
|
changes in our senior management;
|
•
|
sales of substantial amounts of our common stock by our directors and executive officers or principal stockholders, or the perception that such sales could occur; and
|
•
|
the risks described in “Risks Related to Our Business” above.
|
|
12/31/2013
|
|
12/31/2014
|
|
12/31/2015
|
|
12/31/2016
|
|
12/31/2017
|
|
12/31/2018
|
||||||||||||
WellCare Health Plans, Inc.
|
$
|
100
|
|
|
$
|
117
|
|
|
$
|
111
|
|
|
$
|
195
|
|
|
$
|
286
|
|
|
$
|
335
|
|
S&P 500 Index
|
$
|
100
|
|
|
$
|
114
|
|
|
$
|
115
|
|
|
$
|
129
|
|
|
$
|
157
|
|
|
$
|
150
|
|
S&P MHCI
|
$
|
100
|
|
|
$
|
138
|
|
|
$
|
163
|
|
|
$
|
206
|
|
|
$
|
294
|
|
|
$
|
339
|
|
|
|
For the Years Ended December 31,
|
||||||||||||||||||
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
|
2014
|
||||||||||
|
|
(In millions, except per share data)
|
||||||||||||||||||
Consolidated operating results:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Total revenues
|
|
$
|
20,414.1
|
|
|
$
|
17,007.2
|
|
|
$
|
14,237.1
|
|
|
$
|
13,890.2
|
|
|
$
|
12,959.9
|
|
Income from operations
|
|
698.3
|
|
|
469.0
|
|
|
529.5
|
|
|
336.1
|
|
|
148.3
|
|
|||||
Income before income taxes
|
|
692.8
|
|
|
461.6
|
|
|
529.5
|
|
|
336.1
|
|
|
177.8
|
|
|||||
Net income
|
|
$
|
439.8
|
|
|
$
|
373.7
|
|
|
$
|
242.1
|
|
|
$
|
118.6
|
|
|
$
|
63.7
|
|
Net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Basic
|
|
$
|
9.40
|
|
|
$
|
8.40
|
|
|
$
|
5.47
|
|
|
$
|
2.69
|
|
|
$
|
1.45
|
|
Diluted
|
|
$
|
9.29
|
|
|
$
|
8.31
|
|
|
$
|
5.43
|
|
|
$
|
2.67
|
|
|
$
|
1.44
|
|
Operating Statistics:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Medical benefits ratio:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Medicaid Health Plans (GAAP)
|
|
86.0
|
%
|
|
87.8
|
%
|
|
86.2
|
%
|
|
86.7
|
%
|
|
88.2
|
%
|
|||||
Medicaid Health Plans (adjusted)
(1)
|
|
88.9
|
%
|
|
88.8
|
%
|
|
89.5
|
%
|
|
89.8
|
%
|
|
90.5
|
%
|
|||||
Medicare Health Plans
|
|
84.7
|
%
|
|
86.0
|
%
|
|
84.6
|
%
|
|
87.2
|
%
|
|
88.5
|
%
|
|||||
Medicare PDPs
|
|
72.4
|
%
|
|
82.4
|
%
|
|
73.7
|
%
|
|
78.7
|
%
|
|
92.9
|
%
|
|||||
SG&A ratio (GAAP)
(2)
|
|
8.3
|
%
|
|
8.7
|
%
|
|
8.0
|
%
|
|
8.2
|
%
|
|
7.9
|
%
|
|||||
Adjusted SG&A ratio
(2) (3)
|
|
8.3
|
%
|
|
8.5
|
%
|
|
8.0
|
%
|
|
7.9
|
%
|
|
7.7
|
%
|
|||||
Membership:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Medicaid Health Plans
|
|
3,931,000
|
|
|
2,723,000
|
|
|
2,544,000
|
|
|
2,388,000
|
|
|
2,310,000
|
|
|||||
Medicare Health Plans
|
|
545,000
|
|
|
496,000
|
|
|
345,000
|
|
|
354,000
|
|
|
417,000
|
|
|||||
Medicare PDPs
|
|
1,057,000
|
|
|
1,152,000
|
|
|
1,009,000
|
|
|
1,025,000
|
|
|
1,392,000
|
|
|||||
Corporate and Other
|
|
5,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Total Membership
|
|
5,538,000
|
|
|
4,371,000
|
|
|
3,898,000
|
|
|
3,767,000
|
|
|
4,119,000
|
|
|||||
Consolidated cash flows:
|
|
|
|
|
|
|
|
|
||||||||||||
Operating activities
|
|
$
|
279.0
|
|
|
$
|
1,050.0
|
|
|
$
|
748.3
|
|
|
$
|
712.6
|
|
|
$
|
299.3
|
|
Investing activities
(4)
|
|
(2,568.0
|
)
|
|
(1,736.5
|
)
|
|
61.1
|
|
|
(172.6
|
)
|
|
(16.0
|
)
|
|||||
Financing activities
|
|
1,742.6
|
|
|
828.2
|
|
|
833.1
|
|
|
505.1
|
|
|
(392.7
|
)
|
|||||
Balance Sheet Data (in millions, as of December 31):
|
|
|
|
|
|
|
|
|
||||||||||||
Cash and cash equivalents
|
|
$
|
3,653.9
|
|
|
$
|
4,198.6
|
|
|
$
|
3,961.4
|
|
|
$
|
2,407.0
|
|
|
$
|
1,313.5
|
|
Total assets
|
|
11,764.7
|
|
|
8,364.6
|
|
|
6,152.8
|
|
|
5,145.8
|
|
|
4,446.5
|
|
|||||
Long-term debt, including current maturities
|
|
2,126.4
|
|
|
1,182.4
|
|
|
997.6
|
|
|
1,199.1
|
|
|
888.6
|
|
|||||
Total liabilities
|
|
7,524.7
|
|
|
5,947.9
|
|
|
4,152.7
|
|
|
3,417.5
|
|
|
2,850.6
|
|
|||||
Total stockholders' equity
|
|
4,240.0
|
|
|
2,416.7
|
|
|
2,000.1
|
|
|
1,728.3
|
|
|
1,595.9
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
(1)
|
For GAAP reporting purposes, Medicaid premium taxes and Medicaid ACA industry fee reimbursements are included in premium revenue to measure our MBR. Our Medicaid Health Plans Adjusted MBR measures the ratio of our medical benefits expense to premium revenue, excluding Medicaid premium taxes and Medicaid ACA industry fee reimbursement revenue. Because reimbursements for Medicaid premium tax and ACA industry fee are both included in the premium rates or reimbursement established in certain of our Medicaid contracts and also recognized separately as a component of expense, we exclude these reimbursements from premium revenue when calculating key ratios as we believe that these components are not indicative of operating performance.
|
(2)
|
Effective January 1, 2018, the Company redefined our SG&A ratio (GAAP) to be a percentage of total revenues. Adjusted SG&A ratio was redefined to be a percentage of total revenues excluding Medicaid premium tax reimbursement and Medicaid ACA industry fee reimbursement. Accordingly, results for the years ended 2017, 2016, 2015 and 2014 were adjusted to conform to this presentation. Our SG&A ratio (GAAP)
|
(3)
|
Our Adjusted SG&A expense ratio measures selling, general and administrative expense as a percentage of total revenues, excluding Medicaid premium tax reimbursement for all years presented and the Medicaid ACA industry fee reimbursements for the years ended December 31, 2018, 2016, 2015 and 2014. The Medicaid ACA industry fee reimbursement was not applicable for the year ended December 31, 2017 due to the one-year moratorium. The ratio also excludes the effect of investigation costs for all years presented, Sterling divestiture, Iowa SG&A and pharmacy benefit manager ("PBM") transitory costs; and certain costs associated with our acquisitions of Meridian, Universal American and the Aetna Part D membership, as applicable.
|
(4)
|
Net cash used in investment activities has been retrospectively adjusted to reflect the adoption of ASU 2016-18,
"Statement of Cash Flows (Topic 230): Restricted Cash"
effective January 1, 2018. Accordingly, investment activities for years ended 2017, 2016, 2015 and 2014 were adjusted by $95.5 million, ($88.1) million, $48.4 million and ($59.6) million, respectively. See Note 2 -
Summary of Significant Accounting Policie
s for further discussion.
|
▪
|
Membership
increased by
1,167,000
members, or
26.7%
, in
2018
compared with
2017
, as discussed below in "
Results of Operations
." The growth was primarily driven by our September 2018 acquisition of Meridian, as well as organic growth in our Medicaid Health Plans and Medicare Health Plans segments. These increases were partially offset by decreased membership in our Medicare PDP segment resulting from our 2018 bid positioning.
|
▪
|
Premiums
increased
$3.2 billion
, or
18.8%
, in
2018
compared with
2017
, primarily reflecting our acquisitions of Meridian in September 2018 and Universal American in April 2017. The increase is also attributed to the assignment of additional members in our Illinois Medicaid health plan, effective January 1, 2018, participation in the Missouri Medicaid program expansion, effective May 1, 2017, organic growth in our Medicare Health Plans segment and the expiration of the 2017 ACA industry fee moratorium (discussed in
Key Development and Accomplishments
below), which reestablished the associated Medicaid ACA industry fee reimbursements from our state government partners for 2018. These increases were partially offset by the previously discussed membership declines in our PDP segment.
|
▪
|
Net Income
increased
$66.1 million
, or
17.7%
, in
2018
compared with
2017
driven by continued improvement in operational execution across all of our segments, the acquisition of Universal American in April 2017 and the effect of the
Tax Cuts and Jobs Act of 2017
("TCJA"), which reduced the U.S. federal statutory corporate income tax rate from 35% to 21% effective January 1, 2018. These increases are partially offset by the favorable effect of revaluing our deferred tax assets and liabilities in 2017 as a result of the
TCJA,
the expiration of the 2017 ACA industry fee moratorium and reestablishment of the ACA industry fee for 2018, which is nondeductible for tax purposes.
|
•
|
In February 2019, we received notice from the North Carolina Department of Health and Human Services (“DHHS”) that we were awarded a contract to administer the state’s Medicaid Prepaid Health Plans, which is subject to a protest process. DHHS has selected four health plans, including us, to serve North Carolina's Medicaid beneficiaries on a statewide basis. One additional health plan led by providers was selected to operate health plans in certain regions. The state is expected to implement the new managed care program, in two phases, for its 1.6 million Medicaid beneficiaries beginning November 1, 2019.
|
•
|
In November 2018, we completed the asset purchase of Aetna Inc.'s ("Aetna") entire standalone Medicare Part D prescription drug plan membership ("Aetna Part D membership"), which Aetna divested as part of CVS Health Corporation's acquisition of Aetna, for total approximate consideration of
$107.2 million
in cash, which is subject to certain true-up provisions. Per the terms of the agreements, Aetna will provide administrative services to, and retain financial risk of, the Aetna Part D membership through 2019. Therefore, the Aetna Part D membership will be excluded from our membership and results of operations until January 1, 2020.
|
•
|
In September 2018, we completed the acquisition of Meridian for approximately
$2.5 billion
in cash, subject to certain purchase price adjustments. As a result of this transaction, we expanded our Medicaid portfolio through the addition of Michigan, where Meridian has the leading market position; expanded our Medicaid presence in Illinois; and acquired an integrated PBM platform. Meridian also serves MA members in Illinois, Indiana, Michigan and Ohio, as well as Health Insurance Marketplace members in Michigan.
|
•
|
In August 2018, we completed a public offering and issuance of
5,207,547
shares of our common stock, at an offering price of $
265.00
per share. The net proceeds from the offering were approximately
$1.3 billion
, after deducting underwriting discounts and offering costs of $
37.7 million
. We used the net proceeds to fund a portion of the cash consideration for the acquisition of Meridian.
|
•
|
In August 2018, we completed the offering and sale of
5.375%
unsecured senior notes due 2026 in the aggregate principal amount of $750.0 million (the “2026 Notes"). The aggregate net proceeds from the issuance of the 2026 Notes were $739.0 million, which were used to fund a portion of the cash consideration for our acquisition of Meridian.
|
•
|
In August 2018, $225.0 million was drawn on our Revolving Credit Facility to partially fund the Meridian acquisition, of which $25.0 million was repaid during September 2018. As of December 31, 2018, $200.0 million was outstanding under the Revolving Credit Facility.
|
•
|
In July 2018, we entered into an amended and restated Credit Agreement (“Amended and Restated Credit Agreement”), which increased the aggregate principle amount available under our Revolving Credit Facility from $
1.0 billion
to $
1.3 billion
. Additionally, we extended the maturity date under the Revolving Credit Facility from January 2021 to July 2023.
|
•
|
In July 2018, we received a Notice of Intent to Award a contract from the Florida Department of Health to provide statewide-managed care services to more than 60,000 children with medically complex conditions through the Children's Medical Services Managed Care Plan ("CMS Plan"). The five-year contract award began on February 1, 2019; however, this contract is still subject to protest and appeal. Additionally, in April 2018, we received a Notice of Agency Decision from the Florida Agency for Health Care Administration (“AHCA”) to award our subsidiary, Staywell, a new five-year contract to provide managed care services to Medicaid-eligible beneficiaries, including Managed Medical Assistance and Long-Term Care beneficiaries in 10 of 11 regions. As part of the Medicaid Managed Care program, we expect to provide statewide managed care services to beneficiaries in the Serious Mental Illness Specialty Plan ("SMI"), which currently has more than 75,000 beneficiaries statewide. We are one of two managed care plans providing services to the SMI beneficiaries. The new statewide Medicaid Managed Care program began on December 1, 2018.
|
•
|
In March 2018, we announced that our Arizona subsidiary, Care1st Health Plan Arizona, Inc., was selected to enter into a contract with the Arizona Health Care Cost Containment System ("AHCCCS") to coordinate the provision of physical and behavioral healthcare services in the Central and North geographic service areas ("GSAs"). Under the
|
•
|
Effective January 1, 2017, the
Consolidated Appropriations Act, 2016
provided for a one-year moratorium on the ACA industry fee, which also eliminated the associated Medicaid ACA industry fee reimbursements from our state government partners. This 2017 moratorium expired effective January 1, 2018. Accordingly, we incurred
$344.1 million
of ACA industry fee expense for 2018. We did not incur ACA industry fee expense for 2017. Additionally, we recognized
$302.2 million
in Medicaid ACA industry fee reimbursement revenue for 2018. We did not receive any Medicaid ACA industry fee reimbursement revenue during 2017.
|
|
For the Years Ended December 31,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
Revenues:
|
(Dollars in millions)
|
||||||||||
Premium
|
$
|
20,146.3
|
|
|
$
|
16,960.3
|
|
|
$
|
14,220.9
|
|
Products and services
|
154.1
|
|
|
—
|
|
|
—
|
|
|||
Investment and other income
|
113.7
|
|
|
46.9
|
|
|
16.2
|
|
|||
Total revenues
|
20,414.1
|
|
|
17,007.2
|
|
|
14,237.1
|
|
|||
Expenses and other:
|
|
|
|
|
|
|
|
|
|||
Medical benefits
|
17,128.1
|
|
|
14,744.8
|
|
|
12,089.4
|
|
|||
Costs of products and services
|
148.6
|
|
|
—
|
|
|
—
|
|
|||
Selling, general and administrative
|
1,701.0
|
|
|
1,484.7
|
|
|
1,133.1
|
|
|||
ACA industry fee
|
344.1
|
|
|
—
|
|
|
228.4
|
|
|||
Medicaid premium taxes
|
126.8
|
|
|
119.8
|
|
|
110.0
|
|
|||
Depreciation and amortization
|
179.7
|
|
|
120.4
|
|
|
87.6
|
|
|||
Interest
|
87.5
|
|
|
68.5
|
|
|
59.1
|
|
|||
Total expenses, net
|
19,715.8
|
|
|
16,538.2
|
|
|
13,707.6
|
|
|||
Income from operations
|
698.3
|
|
|
469.0
|
|
|
529.5
|
|
|||
Loss on extinguishment of debt
|
—
|
|
|
26.1
|
|
|
—
|
|
|||
Income before income taxes and equity in earnings of unconsolidated subsidiaries
|
698.3
|
|
|
442.9
|
|
|
529.5
|
|
|||
Equity in (losses) earnings of unconsolidated subsidiaries
|
(5.5
|
)
|
|
18.7
|
|
|
—
|
|
|||
Income before income taxes
|
692.8
|
|
|
461.6
|
|
|
529.5
|
|
|||
Income tax expense
|
253.0
|
|
|
87.9
|
|
|
287.4
|
|
|||
Net income
|
$
|
439.8
|
|
|
$
|
373.7
|
|
|
$
|
242.1
|
|
|
|
|
|
|
|
||||||
Effective tax rate
|
36.5
|
%
|
|
19.0
|
%
|
|
54.3
|
%
|
|||
|
|
|
|
|
|
||||||
Membership by Segment
|
|
|
|
|
|
||||||
Medicaid Health Plans
|
3,931,000
|
|
|
2,723,000
|
|
|
2,544,000
|
|
|||
Medicare Health Plans
|
545,000
|
|
|
496,000
|
|
|
345,000
|
|
|||
Medicare PDPs
|
1,057,000
|
|
|
1,152,000
|
|
|
1,009,000
|
|
|||
Total Membership by Segment
|
5,533,000
|
|
|
4,371,000
|
|
|
3,898,000
|
|
|||
Health Insurance Marketplace
|
5,000
|
|
|
—
|
|
|
—
|
|
|||
Total Membership
|
5,538,000
|
|
|
4,371,000
|
|
|
3,898,000
|
|
|||
|
|
|
|
|
|
•
|
Medicaid Health Plans.
Membership increased by
1,208,000
, or
44.4%
, to
3.9 million
members as of
December 31, 2018
.The increase was primarily driven by the acquisition of Meridian, as well as organic membership growth primarily in our Illinois Medicaid health plan as a result of a new contract with the Illinois Department of Health Care and Family Services ("HFS") to administer the Health Choice Illinois Medicaid managed care program statewide, effective January 1, 2018.
|
•
|
Medicare Health Plans.
Membership increased by
49,000
, or
9.9%
, to
545,000
members as of
December 31, 2018
. The increase is partially a result of the acquisition of Meridian, which expanded our membership through the addition of Michigan, Indiana and Ohio, as well as deepened our presence in Illinois. Additionally, the increase reflects our organic growth.
|
•
|
Medicare PDPs.
Membership decreased by
95,000
, or
8.2%
, to
1.1 million
members as of
December 31, 2018
. The decrease was primarily the result of our 2018 bid positioning. Our 2018 PDP bids resulted in one of our basic plans being below CMS benchmarks in 25 of the 34 CMS regions, and within the
de minimis
range in five other regions, compared with our 2017 bids, in which we were below the benchmarks in 30 of the 34 CMS regions, and within the
de minimis
range in three other regions.
|
•
|
Medicaid Health Plans
. Membership increased by 179,000, or 7.0%, to 2.7 million members as of
December 31, 2017
. The increase was primarily driven by our participation in Missouri's Medicaid program statewide expansion, our new Nebraska Medicaid plan, and membership acquired from Phoenix Health Plan in our Arizona market. The increase was partially offset by declines in our Georgia health plan membership because the State added a fourth managed care organization, effective July 1, 2017.
|
•
|
Medicare Health Plans
. Membership increased by 151,000, or 43.8%, to 496,000 members as of
December 31, 2017
. The increase primarily reflects our acquisition of Universal American, our 2017 bid positioning and continued execution on sales and retention initiatives, partially offset by planned service area reductions for the 2017 plan year.
|
•
|
Medicare PDPs
. Membership increased by 143,000, or 14.2%, to 1.2 million members as of
December 31, 2017
. The increase was primarily the result of our 2017 bid positioning. Our 2017 PDP bids resulted in one of our basic plans being below the benchmarks in 30 of the 34 CMS regions, and within the
de minimis
range in three other regions. Our 2016 PDP bids resulted in one of our basic plans being below the benchmarks in 17 of the 34 CMS regions, and within the
de minimis
range in nine other regions.
|
|
For the Years Ended December 31,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
Gross Margin
(1)
:
|
(In millions)
|
||||||||||
Medicaid Health Plans
|
$
|
1,478.4
|
|
|
$
|
1,192.4
|
|
|
$
|
1,052.8
|
|
Medicare Health Plans
|
856.6
|
|
|
742.9
|
|
|
533.9
|
|
|||
Medicare PDPs
|
211.9
|
|
|
160.4
|
|
|
206.4
|
|
|||
Corporate and other
(2)
|
5.9
|
|
|
—
|
|
|
—
|
|
|||
Total gross margin
|
2,552.8
|
|
|
2,095.7
|
|
|
1,793.1
|
|
|||
Investment and other income
|
113.7
|
|
|
46.9
|
|
|
16.2
|
|
|||
Other expenses, net
(3)
|
(1,968.2
|
)
|
|
(1,673.6
|
)
|
|
(1,279.8
|
)
|
|||
Income from operations
|
$
|
698.3
|
|
|
$
|
469.0
|
|
|
$
|
529.5
|
|
|
|
|
|
|
|
(1)
|
Effective
January 1, 2018
, the Company redefined gross margin as total revenues less investment and other income, medical benefits expense, costs of products and services, the ACA industry fee expense, and Medicaid premium tax expense. Accordingly, results for the years ended
December 31, 2017
and
2016
were adjusted to include Medicaid premium taxes, which decreased gross margin by
$119.8 million
and
$110.0 million
, respectively.
|
(2)
|
Corporate and other category includes businesses that are not individually reportable because they do not meet the quantitative thresholds required by generally accepted accounting principles.
|
(3)
|
Effective
January 1, 2018
, other expenses include SG&A expenses, depreciation, amortization and interest. Accordingly, results for the years ended
December 31, 2017
and
2016
were adjusted to exclude Medicaid premium taxes, which decreased other expenses by
$119.8 million
and
$110.0 million
, respectively.
|
|
For the Years Ended December 31,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
|
(In millions)
|
||||||||||
Premium revenue
(1)
|
$
|
12,563.8
|
|
|
10,606.5
|
|
|
9,144.4
|
|
||
Medicaid premium tax reimbursement
(1)
|
126.8
|
|
|
119.8
|
|
|
110.0
|
|
|||
Medicaid ACA industry fee reimbursement
(1)
|
302.2
|
|
|
—
|
|
|
244.9
|
|
|||
Total premiums
|
12,992.8
|
|
|
10,726.3
|
|
|
9,499.3
|
|
|||
Medical benefits expense
|
11,171.3
|
|
|
9,414.1
|
|
|
8,188.5
|
|
|||
Medicaid premium tax
|
126.8
|
|
|
119.8
|
|
|
110.0
|
|
|||
ACA industry fee
|
216.3
|
|
|
—
|
|
|
148.0
|
|
|||
Gross margin
(2)
|
$
|
1,478.4
|
|
|
$
|
1,192.4
|
|
|
$
|
1,052.8
|
|
|
|
|
|
|
|
||||||
Medicaid Health Plans MBR
(1)
|
86.0
|
%
|
|
87.8
|
%
|
|
86.2
|
%
|
|||
Effect of:
|
|
|
|
|
|
||||||
Medicaid premium taxes
|
0.9
|
%
|
|
1.1
|
%
|
|
1.0
|
%
|
|||
Medicaid ACA industry fee reimbursement
|
2.0
|
%
|
|
—
|
%
|
|
2.3
|
%
|
|||
Medicaid Health Plans Adjusted MBR
(1)
|
88.9
|
%
|
|
88.8
|
%
|
|
89.5
|
%
|
|||
|
|
|
|
|
|
||||||
Medicaid Health Plans Membership:
|
|
|
|
|
|
|
|
|
|||
Illinois
|
842,000
|
|
|
138,000
|
|
|
166,000
|
|
|||
Florida
|
777,000
|
|
|
751,000
|
|
|
780,000
|
|
|||
Michigan
|
500,000
|
|
|
—
|
|
|
—
|
|
|||
Georgia
|
493,000
|
|
|
513,000
|
|
|
571,000
|
|
|||
Kentucky
|
444,000
|
|
|
448,000
|
|
|
440,000
|
|
|||
Other states
(3)
|
875,000
|
|
|
873,000
|
|
|
587,000
|
|
|||
|
3,931,000
|
|
|
2,723,000
|
|
|
2,544,000
|
|
|||
|
|
|
|
|
|
(1)
|
For GAAP reporting purposes, Medicaid premium tax reimbursement and Medicaid ACA industry fee reimbursement are included in premium revenue to measure our MBR. Our Medicaid Health Plans Adjusted MBR measures the ratio of our medical benefits expense to premium revenue, excluding Medicaid premium tax reimbursement and Medicaid ACA industry fee reimbursement revenue. Because reimbursements for Medicaid premium tax and ACA industry fee are both included in the premium rates or reimbursement established in certain of our Medicaid contracts and also recognized separately as a component of expense, we exclude these reimbursements from premium revenue when calculating key ratios as we believe that these components are not indicative of operating performance.
|
(2)
|
Effective
January 1, 2018
, the Company redefined gross margin as total revenues less investment and other income, medical benefits expense, costs of products and services, the ACA industry fee expense, and Medicaid premium tax expense. Accordingly, results for the years ended
December 31, 2017
and
2016
were adjusted to include Medicaid premium taxes, which decreased gross margin by
$119.8 million
and
$110.0 million
, respectively.
|
(3)
|
"All other states" consists of Arizona, Hawaii, Missouri, New Jersey, New York, South Carolina and Texas. In 2017 and 2018, it also includes Nebraska.
|
|
For the Years Ended December 31,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
|
(In millions)
|
||||||||||
Premium revenue
|
$
|
6,313.8
|
|
|
$
|
5,320.2
|
|
|
$
|
3,876.6
|
|
Medical benefits expense
|
5,347.8
|
|
|
4,577.3
|
|
|
3,278.5
|
|
|||
ACA industry fee
|
109.4
|
|
|
—
|
|
|
64.2
|
|
|||
Gross margin
|
$
|
856.6
|
|
|
$
|
742.9
|
|
|
$
|
533.9
|
|
|
|
|
|
|
|
||||||
Medicare Health Plans Membership
|
545,000
|
|
|
496,000
|
|
|
345,000
|
|
|||
|
|
|
|
|
|
||||||
Medicare Health Plans MBR
|
84.7
|
%
|
|
86.0
|
%
|
|
84.6
|
%
|
|||
|
|
|
|
|
|
|
For the Years Ended December 31,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
|
(In millions)
|
||||||||||
Premium revenue
|
$
|
835.0
|
|
|
$
|
913.8
|
|
|
$
|
845.0
|
|
Medical benefits expense
|
604.8
|
|
|
753.4
|
|
|
622.4
|
|
|||
ACA industry fee
|
18.3
|
|
|
—
|
|
|
16.2
|
|
|||
Gross margin
|
$
|
211.9
|
|
|
$
|
160.4
|
|
|
$
|
206.4
|
|
|
|
|
|
|
|
||||||
Medicare PDPs membership
|
1,057,000
|
|
|
1,152,000
|
|
|
1,009,000
|
|
|||
|
|
|
|
|
|
||||||
Medicare PDPs MBR
|
72.4
|
%
|
|
82.4
|
%
|
|
73.7
|
%
|
|||
|
|
|
|
|
|
•
|
payment of medical claims and other health care services;
|
•
|
payment of certain Part D benefits paid for members on behalf of CMS;
|
•
|
SG&A costs directly incurred or paid through a management services agreement to one of our non-regulated administrative and management services subsidiaries; and
|
•
|
federal tax payments to the parent company under an intercompany tax sharing agreement.
|
•
|
generating cash flows from operating activities, primarily from premium revenue;
|
•
|
receipts of prospective subsidy payments and related final settlements from CMS to reimburse us for certain Part D benefits paid for members on behalf of CMS;
|
•
|
cash flows from investing activities, including investment income and sales of investments; and
|
•
|
capital contributions received from our non-regulated subsidiaries.
|
•
|
payment of administrative costs not directly incurred by our regulated operations, including, but not limited to, staffing costs, business development, rent, branding and certain information technology services;
|
•
|
capital contributions paid to our regulated subsidiaries;
|
•
|
capital expenditures;
|
•
|
acquisition-related funding and transaction expenses;
|
•
|
debt service; and
|
•
|
federal and state tax payments.
|
•
|
management fees earned by our non-regulated administrator subsidiary under management services agreements;
|
•
|
dividends received from our regulated subsidiaries;
|
•
|
collecting federal and state tax payments from the regulated subsidiaries;
|
•
|
proceeds from issuance of debt and equity securities; and
|
•
|
cash flows from investing activities, including investment income and sales of investments.
|
|
For the Years Ended December 31,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
|
(In millions)
|
||||||||||
Net cash provided by operating activities
|
$
|
279.0
|
|
|
$
|
1,050.0
|
|
|
$
|
748.3
|
|
Net cash used in investing activities
(1)
|
(2,568.0
|
)
|
|
(1,736.5
|
)
|
|
61.1
|
|
|||
Net cash provided by financing activities
|
1,742.6
|
|
|
828.2
|
|
|
833.1
|
|
|||
(Decrease) increase in cash, cash equivalents and restricted cash and cash equivalents
(1)
|
$
|
(546.4
|
)
|
|
$
|
141.7
|
|
|
$
|
1,642.5
|
|
|
|
|
|
|
|
•
|
Net proceeds of approximately $
1.3 billion
from an issuance of
5,207,547
shares of our common stock, after deducting underwriting discounts and offering costs.
|
•
|
Net proceeds of
$935.3 million
resulting from debt transactions executed in 2018, including net proceeds of
$739.0 million
from the issuance of our 2026 Notes in August 2018 and net borrowings on our Revolving Credit Facility of $196.3 million during the third quarter of 2018, both transactions are net of issuance costs.
|
•
|
Net funds paid for the benefit of members was approximately
$520.6 million
for 2018, compared with net funds received of
$671.6 million
during 2017. These funds represent the net amounts we paid for related prescription drug benefits, described above in "
Medicare Part D Funding and Settlements"
,
net of the amounts of subsidies we received from CMS in connection with the low-income cost sharing, catastrophic reinsurance and coverage gap discount components of the Medicare Part D program related to the government's portion of financial responsibility. The increase in funds paid in 2018 compared with the same period in 2017 is due to
$742.1 million
paid to CMS in November 2018 to settle the 2017 Medicare Part D program plan year, compared with
$92.8 million
paid in 2017 to settle the 2016 plan year, as well as the effect of our 2018 bids, resulting in lower payments received for 2018 net subsidies.
|
•
|
Net funds received for the benefit of members was approximately $671.6 million for
2017
, compared with $1.0 billion during
2016
. These funds represent the net amounts of subsidies we received from CMS in connection with the low-income cost sharing, catastrophic reinsurance and coverage gap discount components of the Medicare Part D program related to the government's portion of financial responsibility, net of the amounts we paid for related prescription drug benefits, described above in "Medicare Part D Funding and Settlements." The decrease in funds received in 2017
|
•
|
Aggregate net proceeds of $156.1 million resulting from debt transactions executed during 2017 reflecting net proceeds of $1.2 billion received from the issuance of our 2025 Notes in March 2017, partially offset by the early redemption in full of our $900.0 million principal amount of 2020 notes in April 2017, including the $25.9 million redemption premium, and a $100.0 million repayment of outstanding borrowings under our Revolving Credit Facility. Refer to "Capital Resources" below for further discussion of our 2017 debt transactions. Debt-related activity for 2016 reflects $200.0 million drawn from our Revolving Credit Facility, which, along with $100.0 million in cash, was used to repay in full the $300.0 million term loan under our prior credit facility.
|
•
|
incur additional indebtedness and issue preferred stock;
|
•
|
pay dividends or make other distributions;
|
•
|
make other restricted payments and investments;
|
•
|
sell assets, including capital stock of restricted subsidiaries;
|
•
|
create certain liens;
|
•
|
incur restrictions on the ability of restricted subsidiaries to pay dividends or make other payments, and in the case of our subsidiaries, guarantee indebtedness;
|
•
|
engage in transactions with affiliates; and
|
•
|
create unrestricted subsidiaries.
|
•
|
incur additional indebtedness and issue preferred stock;
|
•
|
pay dividends or make other distributions;
|
•
|
make other restricted payments and investments;
|
•
|
sell assets, including capital stock of restricted subsidiaries;
|
•
|
create certain liens;
|
•
|
incur restrictions on the ability of restricted subsidiaries to pay dividends or make other payments, and in the case of our subsidiaries, guarantee indebtedness;
|
•
|
engage in transactions with affiliates; and
|
•
|
create unrestricted subsidiaries.
|
|
Payments due to period
|
||||||||||||||||||
|
Total
|
|
Less Than
1 Year
|
|
1 - 3
Years
|
|
3 - 5
Years
|
|
More than
5 Years
|
||||||||||
|
(In millions)
|
||||||||||||||||||
Operating leases
|
$
|
364.3
|
|
|
$
|
42.4
|
|
|
$
|
89.9
|
|
|
$
|
80.6
|
|
|
$
|
151.4
|
|
Purchase obligations
(1)
|
94.1
|
|
|
65.7
|
|
|
25.8
|
|
|
2.6
|
|
|
—
|
|
|||||
Long-term debt
(2)
|
2,150.0
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,150.0
|
|
|||||
Interest on debt
(3)
|
700.6
|
|
|
103.3
|
|
|
206.6
|
|
|
206.6
|
|
|
184.1
|
|
|||||
Total
|
$
|
3,309.0
|
|
|
$
|
211.4
|
|
|
$
|
322.3
|
|
|
$
|
289.8
|
|
|
$
|
2,485.5
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Our purchase obligations include commitments under contracts for equipment leases and software maintenance.
|
(2)
|
Represents the principal amount of the 2025 Notes and 2026 Notes and borrowings outstanding under our Revolving Credit Facility as of
December 31, 2018
. This amount excludes
$23.6 million
of unamortized debt issuance costs, which is reflected as a reduction to our long-term debt in our consolidated balance sheet.
|
(3)
|
Represents projected interest on the 2025 Notes and 2026 Notes. These projections exclude the variable interest on the
$200.0 million
principal amount drawn under the Revolving Credit Facility.
|
|
As of December 31,
|
||||||
|
2018
|
|
2017
|
||||
Liability to states under Medicaid risk sharing provisions
|
$
|
(178.5
|
)
|
|
$
|
(142.5
|
)
|
Liability to CMS under risk corridor and other provisions
|
(232.0
|
)
|
|
(179.1
|
)
|
||
Liability to CMS under MA/PDP minimum MLR provisions of the ACA
|
(19.9
|
)
|
|
(1.2
|
)
|
||
Net payables to government partners
(1)
|
$
|
(430.4
|
)
|
|
$
|
(322.8
|
)
|
|
|
|
|
|
As of December 31,
|
||||||
|
2018
|
|
2017
|
||||
Low-income cost sharing subsidy
|
$
|
97.7
|
|
|
$
|
(47.7
|
)
|
Catastrophic reinsurance subsidy
|
(583.2
|
)
|
|
(987.1
|
)
|
||
Coverage gap discount subsidy
|
(20.5
|
)
|
|
(13.6
|
)
|
||
Funds payable for the benefit of members, net
(1)
|
$
|
(506.0
|
)
|
|
$
|
(1,048.4
|
)
|
|
|
|
|
|
December 31, 2018
|
|
% of
Total
|
|
December 31, 2017
|
|
% of
Total
|
||||
|
(In millions)
|
||||||||||
IBNR
|
$
|
2,029.8
|
|
|
70%
|
|
$
|
1,412.3
|
|
|
66%
|
Other medical benefits payable
|
867.6
|
|
|
30%
|
|
734.0
|
|
|
34%
|
||
Total medical benefits payable
|
$
|
2,897.4
|
|
|
100%
|
|
$
|
2,146.3
|
|
|
100%
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
|
(In millions)
|
||||||||||
Balances as of beginning of period
|
$
|
2,146.3
|
|
|
$
|
1,690.5
|
|
|
$
|
1,536.0
|
|
Acquisitions (divestitures)
|
534.3
|
|
|
128.1
|
|
|
37.3
|
|
|||
Medical benefits incurred related to:
|
|
|
|
|
|
||||||
Current year
(1)
|
17,603.4
|
|
|
15,112.4
|
|
|
12,374.1
|
|
|||
Prior year
|
(475.3
|
)
|
|
(367.6
|
)
|
|
(284.7
|
)
|
|||
Total
|
17,128.1
|
|
|
14,744.8
|
|
|
12,089.4
|
|
|||
Medical benefits paid related to:
|
|
|
|
|
|
||||||
Current year
|
(15,486.3
|
)
|
|
(13,355.9
|
)
|
|
(10,925.0
|
)
|
|||
Prior year
|
(1,425.0
|
)
|
|
(1,061.2
|
)
|
|
(1,047.2
|
)
|
|||
Total
|
(16,911.3
|
)
|
|
(14,417.1
|
)
|
|
(11,972.2
|
)
|
|||
Balances as of end of year
|
$
|
2,897.4
|
|
|
$
|
2,146.3
|
|
|
$
|
1,690.5
|
|
|
|
|
|
|
|
(a)
|
Evaluation of Disclosure Controls and Procedures
|
(b)
|
Management's Report on Internal Control Over Financing Reporting
|
(c)
|
Changes in Internal Controls
|
(1)
|
Financial Statements are listed in the Index to Consolidated Financial Statements on page F-1 of this report.
|
(2)
|
Financial Statement Schedules are listed in the Index to Consolidated Financial Statements on Page F-1 of this report.
|
|
Page
|
Report of Independent Registered Public Accounting Firm
|
|
Consolidated Statements of Comprehensive Income for the years ended December 31, 2018, 2017 and 2016
|
|
Consolidated Balance Sheets as of December 31, 2018 and 2017
|
|
Consolidated Statements of Changes in Stockholders' Equity for the years ended December 31, 2018, 2017 and 2016
|
|
Consolidated Statements of Cash Flows for the years ended December 31, 2018, 2017 and 2016
|
|
Notes to Consolidated Financial Statements
|
Schedule I — Condensed Financial Information of Registrant
|
|
For the Years Ended December 31,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
Revenues:
|
|
|
|
|
|
||||||
Premium
|
$
|
20,146.3
|
|
|
$
|
16,960.3
|
|
|
$
|
14,220.9
|
|
Products and services
|
154.1
|
|
|
—
|
|
|
—
|
|
|||
Investment and other income
|
113.7
|
|
|
46.9
|
|
|
16.2
|
|
|||
Total revenues
|
20,414.1
|
|
|
17,007.2
|
|
|
14,237.1
|
|
|||
Expenses and other:
|
|
|
|
|
|
||||||
Medical benefits
|
17,128.1
|
|
|
14,744.8
|
|
|
12,089.4
|
|
|||
Costs of products and services
|
148.6
|
|
|
—
|
|
|
—
|
|
|||
Selling, general and administrative
|
1,701.0
|
|
|
1,484.7
|
|
|
1,133.1
|
|
|||
ACA industry fee
|
344.1
|
|
|
—
|
|
|
228.4
|
|
|||
Medicaid premium taxes
|
126.8
|
|
|
119.8
|
|
|
110.0
|
|
|||
Depreciation and amortization
|
179.7
|
|
|
120.4
|
|
|
87.6
|
|
|||
Interest
|
87.5
|
|
|
68.5
|
|
|
59.1
|
|
|||
Total expenses, net
|
19,715.8
|
|
|
16,538.2
|
|
|
13,707.6
|
|
|||
Income from operations
|
698.3
|
|
|
469.0
|
|
|
529.5
|
|
|||
Loss on extinguishment of debt
|
—
|
|
|
26.1
|
|
|
—
|
|
|||
Income before income taxes and equity in earnings of unconsolidated subsidiaries
|
698.3
|
|
|
442.9
|
|
|
529.5
|
|
|||
Equity in (losses) earnings of unconsolidated subsidiaries
|
(5.5
|
)
|
|
18.7
|
|
|
—
|
|
|||
Income before income taxes
|
692.8
|
|
|
461.6
|
|
|
529.5
|
|
|||
Income tax expense
|
253.0
|
|
|
87.9
|
|
|
287.4
|
|
|||
Net income
|
$
|
439.8
|
|
|
$
|
373.7
|
|
|
$
|
242.1
|
|
|
|
|
|
|
|
||||||
Other comprehensive income, before tax:
|
|
|
|
|
|
||||||
Change in net unrealized gains and losses
on available-for-sale securities
|
(9.1
|
)
|
|
(2.2
|
)
|
|
1.8
|
|
|||
Income tax (benefit) expense related to other
comprehensive (loss) income
|
(2.9
|
)
|
|
(0.5
|
)
|
|
0.6
|
|
|||
Other comprehensive (loss) income, net of tax
|
(6.2
|
)
|
|
(1.7
|
)
|
|
1.2
|
|
|||
Comprehensive income
|
$
|
433.6
|
|
|
$
|
372.0
|
|
|
$
|
243.3
|
|
|
|
|
|
|
|
||||||
Earnings per common share (see Note 5):
|
|
|
|
|
|
|
|
|
|||
Basic
|
$
|
9.40
|
|
|
$
|
8.40
|
|
|
$
|
5.47
|
|
Diluted
|
$
|
9.29
|
|
|
$
|
8.31
|
|
|
$
|
5.43
|
|
|
|
|
|
|
|
||||||
Weighted average common shares outstanding:
|
|
|
|
|
|
||||||
Basic
|
46,767,626
|
|
|
44,474,016
|
|
|
44,248,778
|
|
|||
Diluted
|
47,354,536
|
|
|
44,967,061
|
|
|
44,619,589
|
|
|
December 31,
|
||||||
Assets
|
2018
|
|
2017
|
||||
Current Assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
3,653.9
|
|
|
$
|
4,198.6
|
|
Short-term investments
|
830.1
|
|
|
469.5
|
|
||
Premiums receivable, net
|
1,223.4
|
|
|
453.4
|
|
||
Pharmacy rebates receivable, net
|
460.6
|
|
|
335.0
|
|
||
Funds receivable for the benefit of members
|
187.3
|
|
|
27.5
|
|
||
Prepaid expenses and other current assets, net
|
477.1
|
|
|
335.2
|
|
||
Total current assets
|
6,832.4
|
|
|
5,819.2
|
|
||
|
|
|
|
||||
Property, equipment and capitalized software, net
|
428.2
|
|
|
319.5
|
|
||
Goodwill
|
2,227.7
|
|
|
660.7
|
|
||
Other intangible assets, net
|
996.2
|
|
|
367.9
|
|
||
Long-term investments
|
813.2
|
|
|
766.2
|
|
||
Restricted cash, cash equivalents and investments
|
234.7
|
|
|
211.0
|
|
||
Other assets
|
18.7
|
|
|
4.9
|
|
||
Assets of discontinued operations
|
213.6
|
|
|
215.2
|
|
||
Total Assets
|
$
|
11,764.7
|
|
|
$
|
8,364.6
|
|
|
|
|
|
||||
Liabilities and Stockholders' Equity
|
|
|
|
|
|||
Current Liabilities:
|
|
|
|
||||
Medical benefits payable
|
$
|
2,897.4
|
|
|
$
|
2,146.3
|
|
Unearned premiums
|
1.4
|
|
|
65.9
|
|
||
Accounts payable and accrued expenses
|
964.6
|
|
|
788.1
|
|
||
Funds payable for the benefit of members
|
693.3
|
|
|
1,075.9
|
|
||
Other payables to government partners
|
458.9
|
|
|
367.0
|
|
||
Total current liabilities
|
5,015.6
|
|
|
4,443.2
|
|
||
|
|
|
|
||||
Deferred income tax liability
|
134.2
|
|
|
93.4
|
|
||
Long-term debt, net
|
2,126.4
|
|
|
1,182.4
|
|
||
Other liabilities
|
34.9
|
|
|
13.7
|
|
||
Liabilities of discontinued operations
|
213.6
|
|
|
215.2
|
|
||
Total Liabilities
|
7,524.7
|
|
|
5,947.9
|
|
||
|
|
|
|
||||
Commitments and contingencies (see Note 13)
|
—
|
|
|
—
|
|
||
Stockholders' Equity:
|
|
|
|
||||
Preferred stock, $0.01 par value (20,000,000 authorized, no shares issued or outstanding)
|
—
|
|
|
—
|
|
||
Common stock, $0.01 par value (100,000,000 authorized, 49,993,219 and 44,522,988 shares issued and outstanding at December 31, 2018 and December 31, 2017, respectively)
|
0.5
|
|
|
0.4
|
|
||
Paid-in capital
|
1,981.1
|
|
|
591.5
|
|
||
Retained earnings
|
2,267.3
|
|
|
1,827.5
|
|
||
Accumulated other comprehensive loss
|
(8.9
|
)
|
|
(2.7
|
)
|
||
Total Stockholders' Equity
|
4,240.0
|
|
|
2,416.7
|
|
||
Total Liabilities and Stockholders' Equity
|
$
|
11,764.7
|
|
|
$
|
8,364.6
|
|
|
Common Stock
|
|
Paid in Capital
|
|
Retained Earnings
|
|
Accumulated
Other Comprehensive Loss |
|
Total
Stockholders' Equity |
|||||||||||||
|
Shares
|
|
Amount
|
|
|
|
|
|||||||||||||||
Balance at January 1, 2016
|
44,113,328
|
|
|
$
|
0.4
|
|
|
$
|
518.4
|
|
|
$
|
1,211.7
|
|
|
$
|
(2.2
|
)
|
|
$
|
1,728.3
|
|
Common stock issued for vested stock-based compensation awards
|
255,143
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Repurchase and retirement of shares to satisfy tax withholding requirements
|
(74,590
|
)
|
|
—
|
|
|
(7.0
|
)
|
|
—
|
|
|
—
|
|
|
(7.0
|
)
|
|||||
Stock-based compensation expense, net of forfeitures
|
—
|
|
|
—
|
|
|
35.5
|
|
|
—
|
|
|
—
|
|
|
35.5
|
|
|||||
Comprehensive income
|
—
|
|
|
—
|
|
|
—
|
|
|
242.1
|
|
|
1.2
|
|
|
243.3
|
|
|||||
Balance at December 31, 2016
|
44,293,881
|
|
|
0.4
|
|
|
546.9
|
|
|
1,453.8
|
|
|
(1.0
|
)
|
|
2,000.1
|
|
|||||
Common stock issued for vested stock-based compensation awards
|
332,508
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Repurchase and retirement of shares to satisfy tax withholding requirements
|
(103,401
|
)
|
|
—
|
|
|
(15.2
|
)
|
|
—
|
|
|
—
|
|
|
(15.2
|
)
|
|||||
Stock-based compensation expense, net of forfeitures
|
—
|
|
|
—
|
|
|
59.8
|
|
|
—
|
|
|
—
|
|
|
59.8
|
|
|||||
Comprehensive income (loss)
|
—
|
|
|
—
|
|
|
—
|
|
|
373.7
|
|
|
(1.7
|
)
|
|
372.0
|
|
|||||
Balance at December 31, 2017
|
44,522,988
|
|
|
0.4
|
|
|
591.5
|
|
|
1,827.5
|
|
|
(2.7
|
)
|
|
2,416.7
|
|
|||||
Issuance of common stock, net of issuance costs
|
5,207,547
|
|
|
0.1
|
|
|
1,342.2
|
|
|
—
|
|
|
—
|
|
|
1,342.3
|
|
|||||
Common stock issued for vested equity-compensation awards
|
377,688
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Repurchase and retirement of shares to satisfy tax withholding requirements
|
(115,004
|
)
|
|
—
|
|
|
(23.4
|
)
|
|
—
|
|
|
—
|
|
|
(23.4
|
)
|
|||||
Stock-based compensation expense, net of forfeitures
|
—
|
|
|
—
|
|
|
70.8
|
|
|
—
|
|
|
—
|
|
|
70.8
|
|
|||||
Comprehensive income (loss)
|
—
|
|
|
—
|
|
|
|
|
|
439.8
|
|
|
(6.2
|
)
|
|
433.6
|
|
|||||
Balance at December 31, 2018
|
49,993,219
|
|
|
$
|
0.5
|
|
|
$
|
1,981.1
|
|
|
$
|
2,267.3
|
|
|
$
|
(8.9
|
)
|
|
$
|
4,240.0
|
|
|
As of December 31,
|
||||||
|
2018
|
|
2017
|
||||
Liability to states under Medicaid risk sharing provisions
|
$
|
(178.5
|
)
|
|
$
|
(142.5
|
)
|
Liability to CMS under risk corridor and other provisions
|
(232.0
|
)
|
|
(179.1
|
)
|
||
Liability to CMS under MA/PDP minimum MLR provisions of the ACA
|
(19.9
|
)
|
|
(1.2
|
)
|
||
Net payables to government partners
(1)
|
$
|
(430.4
|
)
|
|
$
|
(322.8
|
)
|
|
|
|
|
|
As of December 31,
|
||||||
|
2018
|
|
2017
|
||||
Low-income cost sharing subsidy
|
$
|
97.7
|
|
|
$
|
(47.7
|
)
|
Catastrophic reinsurance subsidy
|
(583.2
|
)
|
|
(987.1
|
)
|
||
Coverage gap discount subsidy
|
(20.5
|
)
|
|
(13.6
|
)
|
||
Funds payable for the benefit of members, net
(1)
|
$
|
(506.0
|
)
|
|
$
|
(1,048.4
|
)
|
|
|
|
|
•
|
Financial and Quality Performance Goals: Certain of our PSUs are subject to variable accounting as they do not have a grant date fair value for accounting purposes due to the subjective nature of the terms of the PSUs, which precludes a mutual understanding of the key terms and conditions. We recognize expense for PSUs ultimately expected to vest over the requisite service period based on our estimates of progress made towards the achievement of the predetermined performance measures and changes in the market price of our common stock. In March 2016, we issued certain PSUs whereby a mutual understanding of key terms and conditions exist; therefore, for these awards we estimate compensation cost based on the grant date fair value, as well as our estimate of the performance outcome, and recognize the expense ratably over the vesting period of the award with cumulative changes in expense recognized in periods in which performance conditions change or are ultimately met.
|
•
|
Market Based Goals: Beginning in 2016, we issued certain PSUs, which are subject to a market condition (total shareholder return relative to industry peer companies or prescribed stock price growth) and we estimate compensation cost based on the grant date fair value and recognize the expense ratably over the vesting period of the award. For these PSUs, the grant date fair value is measured using a Monte Carlo simulation approach, which estimates the fair value of awards based on randomly generated simulated stock-price paths through a lattice-type structure. PSUs expected to vest are recognized as expense either on a straight-line or accelerated basis, depending on the award structure, over the vesting period.
|
•
|
the length of time and the extent to which the market value has been below cost;
|
•
|
the potential for impairments of securities when the issuer is experiencing significant financial difficulties;
|
•
|
the potential for impairments in an entire industry sector or sub-sector;
|
•
|
the potential for impairments in certain economically depressed geographic locations;
|
•
|
the potential for impairments of securities where the issuer, series of issuers or industry has suffered a catastrophic type of loss or has exhausted natural resources;
|
•
|
unfavorable changes in forecasted cash flows on asset-backed securities; and
|
•
|
other subjective factors, including concentrations and information obtained from regulators and rating agencies.
|
Assets
|
(in millions)
|
||
Cash, cash equivalents and restricted cash
|
$
|
484.4
|
|
Investments, including restricted investments
|
180.4
|
|
|
Premiums receivable, net
|
379.6
|
|
|
Other current assets
|
145.1
|
|
|
Property, equipment and capitalized software, net
|
49.3
|
|
|
Goodwill
|
1,560.7
|
|
|
Other intangible assets, net
|
594.0
|
|
|
Fair value of total assets acquired
|
$
|
3,393.5
|
|
|
|
||
Liabilities
|
|
||
Medical benefits payable
|
$
|
534.3
|
|
ACA Fee liability
|
66.5
|
|
|
Other liabilities
|
272.6
|
|
|
Fair value of liabilities assumed
|
873.4
|
|
|
Fair value of net assets acquired
|
$
|
2,520.1
|
|
|
|
•
|
key assumptions in the valuation of the acquired technology, including, but not limited to, estimated costs associated with developers’ salaries, external direct costs of materials and services; and the estimated time to replace the acquired software applications; and
|
|
|
Gross Fair Value
(in millions)
|
|
Weighted Average
Useful Life (in years)
|
||
Membership
|
|
$
|
378.6
|
|
|
8.9
|
Tradenames
|
|
110.4
|
|
|
4.9
|
|
Provider network
|
|
8.3
|
|
|
15.0
|
|
Technology and other
|
|
96.7
|
|
|
7.1
|
|
Total
|
|
$
|
594.0
|
|
|
8.0
|
|
|
|
|
|
Assets
|
(in millions)
|
||
Cash and cash equivalents
|
$
|
66.4
|
|
Investments, including restricted investments
|
254.4
|
|
|
Premiums receivable, net
|
90.7
|
|
|
Pharmacy rebates receivable, net, and other current assets
|
52.9
|
|
|
Property, equipment and capitalized software, net
|
7.5
|
|
|
Goodwill
|
282.0
|
|
|
Other intangible assets, net
|
298.2
|
|
|
Assets of discontinued operations
|
219.6
|
|
|
Estimated fair value of total assets acquired
|
$
|
1,271.7
|
|
|
|
||
Liabilities
|
|
||
Medical benefits payable
|
$
|
128.1
|
|
Deferred tax liabilities, net
|
67.1
|
|
|
Other liabilities
|
87.8
|
|
|
Liabilities of discontinued operations
|
218.7
|
|
|
Estimated fair value of liabilities assumed
|
501.7
|
|
|
Estimated fair value of net assets acquired
|
$
|
770.0
|
|
|
|
|
|
Gross Fair Value
(in millions)
|
|
Weighted Average
Useful Life (in years)
|
||
Membership
|
|
$
|
240.0
|
|
|
10.0
|
Tradenames
|
|
36.0
|
|
|
13.9
|
|
Provider network
|
|
9.5
|
|
|
15.0
|
|
Technology and other
|
|
12.7
|
|
|
6.2
|
|
Total
|
|
$
|
298.2
|
|
|
10.5
|
|
|
|
|
|
|
|
For the years ended December 31,
|
||||||||||
(in millions, except per share data)
|
|
2018
|
|
2017
|
|
2016
|
||||||
Total revenues
|
|
$
|
23,408.6
|
|
|
$
|
20,598.2
|
|
|
$
|
16,211.4
|
|
Net income
|
|
$
|
420.8
|
|
|
$
|
376.1
|
|
|
$
|
239.0
|
|
Earnings per common share:
|
|
|
|
|
|
|
||||||
Basic
|
|
$
|
8.47
|
|
|
$
|
7.57
|
|
|
$
|
5.40
|
|
Diluted
|
|
$
|
8.16
|
|
|
$
|
7.50
|
|
|
$
|
5.36
|
|
•
|
Elimination of historical intangible asset amortization expense and addition of amortization expense based on the current preliminary values of identified intangible assets;
|
•
|
Elimination of interest expense associated with retired obligations and addition of interest expense based on debt incurred to finance the Meridian transaction;
|
•
|
Elimination of results for Meridian operations not acquired;
|
•
|
Elimination of transaction and integration-related costs for Meridian and Universal American, as well as transaction costs associated with our acquisition of Aetna’s Part D membership;
|
•
|
Elimination of Universal American discontinued operations;
|
•
|
Include
5,207,547
shares of our common stock issued to finance the Meridian transaction;
|
•
|
Adjustments to align the acquisitions to our accounting policies; and
|
•
|
Tax effects of the adjustments noted above.
|
|
Medicaid Health Plan
|
|
Medicare Health Plan
|
|
Medicare PDP
|
|
Corporate & Other
|
|
Consolidated
|
||||||||||
For the Year Ended December 31, 2018
|
(in millions)
|
||||||||||||||||||
Premium
|
$
|
12,992.8
|
|
|
$
|
6,313.8
|
|
|
$
|
835.0
|
|
|
$
|
4.7
|
|
|
$
|
20,146.3
|
|
Products and services
|
—
|
|
|
—
|
|
|
—
|
|
|
154.1
|
|
|
154.1
|
|
|||||
Total premium and products and services revenues
|
12,992.8
|
|
|
6,313.8
|
|
|
835.0
|
|
|
158.8
|
|
|
20,300.4
|
|
|||||
|
|
|
|
|
|
|
|
|
|
||||||||||
Medical benefits
|
11,171.3
|
|
|
5,347.8
|
|
|
604.8
|
|
|
4.2
|
|
|
17,128.1
|
|
|||||
Costs of products and services
|
—
|
|
|
—
|
|
|
—
|
|
|
148.6
|
|
|
148.6
|
|
|||||
ACA industry fee
|
216.3
|
|
|
109.4
|
|
|
18.3
|
|
|
0.1
|
|
|
344.1
|
|
|||||
Medicaid premium taxes
|
126.8
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
126.8
|
|
|||||
Total gross margin expenses
|
11,514.4
|
|
|
5,457.2
|
|
|
623.1
|
|
|
152.9
|
|
|
17,747.6
|
|
|||||
|
|
|
|
|
|
|
|
|
|
||||||||||
Gross margin
(1)
|
1,478.4
|
|
|
856.6
|
|
|
211.9
|
|
|
5.9
|
|
|
2,552.8
|
|
|||||
|
|
|
|
|
|
|
|
|
|
||||||||||
Investment and other income
|
—
|
|
|
—
|
|
|
—
|
|
|
113.7
|
|
|
113.7
|
|
|||||
Other expenses
(2)
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,968.2
|
)
|
|
(1,968.2
|
)
|
|||||
Income from operations
|
$
|
1,478.4
|
|
|
$
|
856.6
|
|
|
$
|
211.9
|
|
|
$
|
(1,848.6
|
)
|
|
$
|
698.3
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
For the Year Ended December 31, 2017
|
|
|
|
|
|
|
|
|
|
||||||||||
Premium
|
$
|
10,726.3
|
|
|
$
|
5,320.2
|
|
|
$
|
913.8
|
|
|
$
|
—
|
|
|
$
|
16,960.3
|
|
Products and services
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Total premium and products and services revenues
|
10,726.3
|
|
|
5,320.2
|
|
|
913.8
|
|
|
—
|
|
|
16,960.3
|
|
|||||
|
|
|
|
|
|
|
|
|
|
||||||||||
Medical benefits
|
9,414.1
|
|
|
4,577.3
|
|
|
753.4
|
|
|
—
|
|
|
14,744.8
|
|
|||||
Costs of products and services
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
ACA industry fee
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Medicaid premium taxes
|
119.8
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
119.8
|
|
|||||
Total gross margin expenses
|
9,533.9
|
|
|
4,577.3
|
|
|
753.4
|
|
|
—
|
|
|
14,864.6
|
|
|||||
|
|
|
|
|
|
|
|
|
|
||||||||||
Gross margin
(1)
|
1,192.4
|
|
|
742.9
|
|
|
160.4
|
|
|
—
|
|
|
2,095.7
|
|
|||||
|
|
|
|
|
|
|
|
|
|
||||||||||
Investment and other income
|
—
|
|
|
—
|
|
|
—
|
|
|
46.9
|
|
|
46.9
|
|
|||||
Other expenses
(2)
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,673.6
|
)
|
|
(1,673.6
|
)
|
|||||
Income from operations
|
$
|
1,192.4
|
|
|
$
|
742.9
|
|
|
$
|
160.4
|
|
|
$
|
(1,626.7
|
)
|
|
$
|
469.0
|
|
|
Medicaid Health Plan
|
|
Medicare Health Plan
|
|
Medicare PDP
|
|
Corporate & Other
|
|
Consolidated
|
||||||||||
For the Year Ended December 31, 2016
|
(in millions)
|
||||||||||||||||||
Premium
|
$
|
9,499.3
|
|
|
$
|
3,876.6
|
|
|
$
|
845.0
|
|
|
$
|
—
|
|
|
$
|
14,220.9
|
|
Products and services
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Total premium and products and services revenues
|
9,499.3
|
|
|
3,876.6
|
|
|
845.0
|
|
|
—
|
|
|
14,220.9
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Medical benefits
|
8,188.5
|
|
|
3,278.5
|
|
|
622.4
|
|
|
—
|
|
|
12,089.4
|
|
|||||
Costs of products and services
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
ACA industry fee
|
148.0
|
|
|
64.2
|
|
|
16.2
|
|
|
—
|
|
|
228.4
|
|
|||||
Medicaid premium taxes
|
110.0
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
110.0
|
|
|||||
Total gross margin expenses
|
8,446.5
|
|
|
3,342.7
|
|
|
638.6
|
|
|
—
|
|
|
12,427.8
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Gross margin (1)
|
1,052.8
|
|
|
533.9
|
|
|
206.4
|
|
|
—
|
|
|
1,793.1
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Investment and other income
|
—
|
|
|
—
|
|
|
—
|
|
|
16.2
|
|
|
16.2
|
|
|||||
Other expenses (2)
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,279.8
|
)
|
|
(1,279.8
|
)
|
|||||
Income from operations
|
$
|
1,052.8
|
|
|
$
|
533.9
|
|
|
$
|
206.4
|
|
|
$
|
(1,263.6
|
)
|
|
$
|
529.5
|
|
(1)
|
Effective January 1, 2018, the Company redefined gross margin as total revenues less investment and other income, medical expenses, cost of products and services, the ACA industry fee expense and Medicaid premium tax expense. Accordingly, results for 2017 and 2016 were adjusted to include Medicaid premium taxes, which decreased gross margin by
$119.8 million
and
$110.0 million
, respectively.
|
(2)
|
Effective January 1, 2018, other expenses includes selling, general and administrative expenses, depreciation, amortization and interest. Accordingly, other expenses for 2017 and 2016 were adjusted to exclude Medicaid premium taxes, which decreased other expenses by $
119.8 million
and $
110.0 million
, respectively.
|
|
For the Years Ended December 31,
|
|||||||
|
2018
|
|
2017
|
|
2016
|
|||
Weighted-average common shares outstanding — basic
|
46,767,626
|
|
|
44,474,016
|
|
|
44,248,778
|
|
Dilutive effect of outstanding stock-based compensation awards
|
586,910
|
|
|
493,045
|
|
|
370,811
|
|
Weighted-average common shares outstanding — diluted
|
47,354,536
|
|
|
44,967,061
|
|
|
44,619,589
|
|
Anti-dilutive stock-based compensation awards excluded from computation
|
211,978
|
|
|
76,446
|
|
|
14,867
|
|
|
|
|
|
|
|
|
Amortized
Cost |
|
Gross
Unrealized Gains |
|
Gross
Unrealized Losses |
|
Estimated
Fair Value |
||||||||
December 31, 2018
|
|
|
|
|
|
|
|
||||||||
Asset-backed securities
|
$
|
144.7
|
|
|
$
|
—
|
|
|
$
|
(0.5
|
)
|
|
$
|
144.2
|
|
Corporate debt securities
|
943.0
|
|
|
0.5
|
|
|
(10.1
|
)
|
|
933.4
|
|
||||
Municipal securities
|
199.6
|
|
|
0.6
|
|
|
(0.9
|
)
|
|
199.3
|
|
||||
Residential mortgage-backed securities
|
7.2
|
|
|
—
|
|
|
(0.2
|
)
|
|
7.0
|
|
||||
Short-term time deposits
|
242.2
|
|
|
—
|
|
|
—
|
|
|
242.2
|
|
||||
Government and agency obligations
|
44.9
|
|
|
—
|
|
|
(0.1
|
)
|
|
44.8
|
|
||||
Other securities
|
72.5
|
|
|
—
|
|
|
(0.1
|
)
|
|
72.4
|
|
||||
Total
|
$
|
1,654.1
|
|
|
$
|
1.1
|
|
|
$
|
(11.9
|
)
|
|
$
|
1,643.3
|
|
December 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
||||
Asset-backed securities
|
$
|
88.9
|
|
|
$
|
—
|
|
|
$
|
(0.2
|
)
|
|
$
|
88.7
|
|
Corporate debt securities
|
400.6
|
|
|
0.7
|
|
|
(1.2
|
)
|
|
400.1
|
|
||||
Municipal securities
|
223.7
|
|
|
1.0
|
|
|
(1.9
|
)
|
|
222.8
|
|
||||
Residential mortgage-backed securities
|
11.2
|
|
|
—
|
|
|
—
|
|
|
11.2
|
|
||||
Short-term time deposits
|
300.4
|
|
|
—
|
|
|
—
|
|
|
300.4
|
|
||||
Government and agency obligations
|
148.7
|
|
|
—
|
|
|
(1.2
|
)
|
|
147.5
|
|
||||
Other securities
|
65.2
|
|
|
—
|
|
|
(0.2
|
)
|
|
65.0
|
|
||||
Total
|
$
|
1,238.7
|
|
|
$
|
1.7
|
|
|
$
|
(4.7
|
)
|
|
$
|
1,235.7
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
Within
1 Year |
|
1 Through 5
Years |
|
5 Through 10
Years |
|
Thereafter
|
||||||||||
Asset-backed securities
|
$
|
144.2
|
|
|
$
|
70.3
|
|
|
$
|
70.1
|
|
|
$
|
1.2
|
|
|
$
|
2.6
|
|
Corporate debt securities
|
933.4
|
|
|
417.0
|
|
|
429.0
|
|
|
79.3
|
|
|
8.1
|
|
|||||
Municipal securities
|
199.3
|
|
|
19.9
|
|
|
115.5
|
|
|
62.5
|
|
|
1.4
|
|
|||||
Residential mortgage-backed securities
|
7.0
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
7.0
|
|
|||||
Short-term time deposits
|
242.2
|
|
|
242.2
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Government and agency obligations
|
44.8
|
|
|
30.9
|
|
|
11.9
|
|
|
2.0
|
|
|
—
|
|
|||||
Other securities
|
72.4
|
|
|
49.8
|
|
|
5.6
|
|
|
3.0
|
|
|
14.0
|
|
|||||
Total
|
$
|
1,643.3
|
|
|
$
|
830.1
|
|
|
$
|
632.1
|
|
|
$
|
148.0
|
|
|
$
|
33.1
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortized
Cost |
|
Gross
Unrealized Gains |
|
Gross
Unrealized Losses |
|
Estimated
Fair Value |
||||||||
December 31, 2018
|
|
|
|
|
|
|
|
||||||||
Cash
|
$
|
11.3
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
11.3
|
|
Money market funds
|
51.4
|
|
|
—
|
|
|
—
|
|
|
51.4
|
|
||||
U.S. government securities and other
|
172.5
|
|
|
—
|
|
|
(0.5
|
)
|
|
172.0
|
|
||||
Total
|
$
|
235.2
|
|
|
$
|
—
|
|
|
$
|
(0.5
|
)
|
|
$
|
234.7
|
|
December 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
||||
Cash
|
$
|
5.7
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
5.7
|
|
Money market funds
|
58.7
|
|
|
—
|
|
|
—
|
|
|
58.7
|
|
||||
U.S. government securities and other
|
147.4
|
|
|
—
|
|
|
(0.8
|
)
|
|
146.6
|
|
||||
Total
|
$
|
211.8
|
|
|
$
|
—
|
|
|
$
|
(0.8
|
)
|
|
$
|
211.0
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
||||||
|
2018
|
|
2017
|
||||
Leasehold improvements
|
$
|
75.5
|
|
|
$
|
36.9
|
|
Computer equipment
|
173.2
|
|
|
128.3
|
|
||
Capitalized software
|
671.7
|
|
|
526.2
|
|
||
Furniture and equipment
|
69.3
|
|
|
39.2
|
|
||
|
989.7
|
|
|
730.6
|
|
||
Less accumulated depreciation
|
(561.5
|
)
|
|
(411.1
|
)
|
||
Total property and equipment, net
|
$
|
428.2
|
|
|
$
|
319.5
|
|
|
|
|
|
|
Medicaid Health Plans
|
|
Medicare Health Plans
|
|
Not Assigned
(4)
|
|
Total
|
||||||||
Balance as of December 31, 2016
(1) (2)
|
$
|
282.1
|
|
|
$
|
110.4
|
|
|
$
|
—
|
|
|
$
|
392.5
|
|
Acquired goodwill
|
8.3
|
|
|
275.6
|
|
|
—
|
|
|
283.9
|
|
||||
Measurement period adjustments
(2)
|
(15.7
|
)
|
|
—
|
|
|
—
|
|
|
(15.7
|
)
|
||||
Balance as of December 31, 2017
(1)
|
274.7
|
|
|
386.0
|
|
|
|
|
660.7
|
|
|||||
Acquired goodwill
(4)
|
—
|
|
|
—
|
|
|
1,560.7
|
|
|
1,560.7
|
|
||||
Measurement period adjustments
(3)
|
—
|
|
|
6.3
|
|
|
—
|
|
|
6.3
|
|
||||
Balance as of December 31, 2018
(1) (4)
|
$
|
274.7
|
|
|
$
|
392.3
|
|
|
$
|
1,560.7
|
|
|
$
|
2,227.7
|
|
|
|
|
|
|
|
|
|
|
As of December 31,
|
||||||||||||||||||||||||
|
2018
|
|
2017
|
||||||||||||||||||||||
|
Weighted Average Amortization Period (In Years)
|
|
Gross Carrying Amount
|
|
Accumulated Amortization
|
|
Other Intangibles, Net
|
|
Gross Carrying Amount
|
|
Accumulated Amortization
|
|
Other Intangibles, Net
|
||||||||||||
Membership and state contracts
|
9.4
|
|
$
|
830.1
|
|
|
$
|
(100.7
|
)
|
|
$
|
729.4
|
|
|
$
|
344.4
|
|
|
$
|
(52.6
|
)
|
|
$
|
291.8
|
|
Trademarks and tradenames
|
7.6
|
|
159.8
|
|
|
(22.6
|
)
|
|
137.2
|
|
|
53.3
|
|
|
(12.9
|
)
|
|
40.4
|
|
||||||
Provider networks
|
15.0
|
|
35.6
|
|
|
(7.0
|
)
|
|
28.6
|
|
|
27.3
|
|
|
(5.1
|
)
|
|
22.2
|
|
||||||
Licenses and permits
|
13.7
|
|
7.9
|
|
|
$
|
(4.5
|
)
|
|
3.4
|
|
|
7.1
|
|
|
(4.1
|
)
|
|
3.0
|
|
|||||
Technology and other
|
6.8
|
|
110.8
|
|
|
(13.2
|
)
|
|
97.6
|
|
|
14.9
|
|
|
(4.4
|
)
|
|
10.5
|
|
||||||
Total other intangible assets
|
9.1
|
|
$
|
1,144.2
|
|
|
$
|
(148.0
|
)
|
|
$
|
996.2
|
|
|
$
|
447.0
|
|
|
$
|
(79.1
|
)
|
|
$
|
367.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2018
|
|
December 31, 2017
|
||||
Long-term debt, net:
|
|
|
|
||||
5.25% Senior Notes, due April 1, 2025
|
$
|
1,200.0
|
|
|
$
|
1,200.0
|
|
5.375% Senior Notes, due August 15, 2026
|
750.0
|
|
|
—
|
|
||
Revolving Credit Facility
|
200.0
|
|
|
—
|
|
||
Debt issuance costs
|
(23.6
|
)
|
|
(17.6
|
)
|
||
Total long-term debt, net
|
$
|
2,126.4
|
|
|
$
|
1,182.4
|
|
|
|
|
|
•
|
incur additional indebtedness and issue preferred stock;
|
•
|
pay dividends or make other distributions;
|
•
|
make other restricted payments and investments;
|
•
|
sell assets, including capital stock of restricted subsidiaries;
|
•
|
create certain liens;
|
•
|
incur restrictions on the ability of restricted subsidiaries to pay dividends or make other payments, and in the case of our subsidiaries, guarantee indebtedness;
|
•
|
engage in transactions with affiliates; and
|
•
|
create unrestricted subsidiaries.
|
(1)
|
at least
50%
of the aggregate principal amount of the 2026 Notes issued under the Indenture (including any additional 2026 Notes, but excluding 2026 Notes held by the Company or its subsidiaries) remains outstanding immediately after the occurrence of such redemption, unless all such 2026 Notes are redeemed substantially concurrently with the redemption of 2026 Notes; and
|
(2)
|
the redemption occurs within
180
days of the date of the closing of such equity offering.
|
•
|
incur additional indebtedness and issue preferred stock;
|
•
|
pay dividends or make distributions;
|
•
|
make other restricted payments and investments;
|
•
|
sell assets, including capital stock of restricted subsidiaries;
|
•
|
create certain liens;
|
•
|
incur restrictions on the ability of restricted subsidiaries to pay dividends or make other payments, and in the case of our subsidiaries, guarantee indebtedness;
|
•
|
engage in transactions with affiliates; and
|
•
|
create unrestricted subsidiaries.
|
|
|
|
Fair Value Measurements Using
|
||||||||||||
|
Carrying Value
|
|
Quoted Prices in
Active Markets for Identical Assets (Level 1) |
|
Significant Other
Observable Inputs (Level 2) |
|
Significant
Unobservable Inputs (Level 3) |
||||||||
Investments:
|
|
|
|
|
|
|
|
||||||||
Asset-backed securities
|
$
|
144.2
|
|
|
$
|
—
|
|
|
$
|
144.2
|
|
|
$
|
—
|
|
Corporate debt securities
|
933.4
|
|
|
—
|
|
|
933.4
|
|
|
—
|
|
||||
Municipal securities
|
199.3
|
|
|
—
|
|
|
199.3
|
|
|
—
|
|
||||
Residential mortgage-backed securities
|
7.0
|
|
|
—
|
|
|
7.0
|
|
|
—
|
|
||||
Short-term time deposits
|
242.2
|
|
|
—
|
|
|
242.2
|
|
|
—
|
|
||||
Government and agency obligations
|
44.8
|
|
|
44.8
|
|
|
—
|
|
|
—
|
|
||||
Other securities
|
72.4
|
|
|
49.8
|
|
|
22.6
|
|
|
—
|
|
||||
Total investments
|
$
|
1,643.3
|
|
|
$
|
94.6
|
|
|
$
|
1,548.7
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
||||||||
Restricted cash, cash equivalents and investments:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Cash
|
$
|
11.3
|
|
|
$
|
11.3
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Money market funds
|
51.4
|
|
|
51.4
|
|
|
—
|
|
|
—
|
|
||||
U.S. government securities and other
|
172.0
|
|
|
171.8
|
|
|
0.2
|
|
|
—
|
|
||||
Total restricted cash, cash equivalents and investments
|
$
|
234.7
|
|
|
$
|
234.5
|
|
|
$
|
0.2
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements Using
|
||||||||||||
|
Carrying Value
|
|
Quoted Prices in Active Markets for Identical Assets
(Level 1) |
|
Significant Other Observable Inputs
(Level 2) |
|
Significant Unobservable Inputs
(Level 3) |
||||||||
Investments:
|
|
|
|
|
|
|
|
||||||||
Asset-backed securities
|
$
|
88.7
|
|
|
$
|
—
|
|
|
$
|
88.7
|
|
|
$
|
—
|
|
Corporate debt securities
|
400.1
|
|
|
—
|
|
|
400.1
|
|
|
—
|
|
||||
Municipal securities
|
222.8
|
|
|
—
|
|
|
210.5
|
|
|
12.3
|
|
||||
Residential mortgage-backed securities
|
11.2
|
|
|
—
|
|
|
11.2
|
|
|
—
|
|
||||
Short-term time deposits
|
300.4
|
|
|
—
|
|
|
300.4
|
|
|
—
|
|
||||
Government and agency obligations
|
147.5
|
|
|
147.5
|
|
|
—
|
|
|
—
|
|
||||
Other securities
|
65.0
|
|
|
52.8
|
|
|
12.2
|
|
|
—
|
|
||||
Total investments
|
$
|
1,235.7
|
|
|
$
|
200.3
|
|
|
$
|
1,023.1
|
|
|
$
|
12.3
|
|
|
|
|
|
|
|
|
|
||||||||
Restricted cash, cash equivalents and investments:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Money market funds
|
$
|
58.7
|
|
|
$
|
58.7
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Cash
|
5.7
|
|
|
5.7
|
|
|
—
|
|
|
—
|
|
||||
U.S. government securities and other
|
146.6
|
|
|
146.4
|
|
|
0.2
|
|
|
—
|
|
||||
Total restricted cash, cash equivalents and investments
|
$
|
211.0
|
|
|
$
|
210.8
|
|
|
$
|
0.2
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
|
||||||||||
|
December 31,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
Balance as of January 1
|
$
|
12.3
|
|
|
$
|
12.4
|
|
|
$
|
31.7
|
|
Realized gains (losses) in earnings
|
(1.2
|
)
|
|
—
|
|
|
—
|
|
|||
Changes in net unrealized gains and losses in other comprehensive income
|
1.4
|
|
|
—
|
|
|
0.9
|
|
|||
Purchases, sales and redemptions
|
(12.5
|
)
|
|
(0.1
|
)
|
|
(20.2
|
)
|
|||
Net transfers in or (out) of Level 3
|
—
|
|
|
—
|
|
|
—
|
|
|||
Balance as of December 31
|
$
|
—
|
|
|
$
|
12.3
|
|
|
$
|
12.4
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements Using
|
|||||||||||
|
Carrying Value
|
|
Quoted Prices in Active Markets for Identical Assets
(Level 1) |
|
Significant Other Observable Inputs
(Level 2) |
|
Significant Unobservable Inputs
(Level 3) |
|||||||
Long-term debt - December 31, 2018
|
$
|
2,126.4
|
|
|
$
|
1,885.2
|
|
|
$
|
200.0
|
|
|
|
|
Long-term debt - December 31, 2017
|
1,182.4
|
|
|
1,274.3
|
|
|
—
|
|
|
—
|
|
(in millions)
|
As of December 31, 2018
|
|
% of
Total |
|
As of December 31, 2017
|
|
% of
Total |
||||
IBNR
|
$
|
2,029.8
|
|
|
70%
|
|
$
|
1,412.3
|
|
|
66%
|
Other medical benefits payable
|
867.6
|
|
|
30%
|
|
734.0
|
|
|
34%
|
||
Total medical benefits payable
|
$
|
2,897.4
|
|
|
100%
|
|
$
|
2,146.3
|
|
|
100%
|
|
|
|
|
|
|
|
|
|
For the years ended December 31,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
|
(in millions)
|
||||||||||
Beginning balance
|
$
|
2,146.3
|
|
|
$
|
1,690.5
|
|
|
$
|
1,536.0
|
|
Acquisitions
|
534.3
|
|
|
128.1
|
|
|
37.3
|
|
|||
Medical benefits incurred related to:
|
|
|
|
|
|
||||||
Current year
(1)
|
17,603.4
|
|
|
15,112.4
|
|
|
12,374.1
|
|
|||
Prior years
|
(475.3
|
)
|
|
(367.6
|
)
|
|
(284.7
|
)
|
|||
Total
|
17,128.1
|
|
|
14,744.8
|
|
|
12,089.4
|
|
|||
Medical benefits paid related to:
|
|
|
|
|
|
||||||
Current year
|
(15,486.3
|
)
|
|
(13,355.9
|
)
|
|
(10,925.0
|
)
|
|||
Prior years
|
(1,425.0
|
)
|
|
(1,061.2
|
)
|
|
(1,047.2
|
)
|
|||
Total
|
(16,911.3
|
)
|
|
(14,417.1
|
)
|
|
(11,972.2
|
)
|
|||
Ending balance
|
$
|
2,897.4
|
|
|
$
|
2,146.3
|
|
|
$
|
1,690.5
|
|
|
|
|
|
|
|
|
For the years ended December 31,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
|
(in millions)
|
||||||||||
Beginning balance
|
$
|
1,373.2
|
|
|
$
|
1,135.8
|
|
|
$
|
1,040.2
|
|
Acquisitions
|
484.0
|
|
|
—
|
|
|
37.3
|
|
|||
Medical benefits incurred related to:
|
|
|
|
|
|
||||||
Current year
(1)
|
11,454.4
|
|
|
9,612.2
|
|
|
8,404.2
|
|
|||
Prior years
|
(283.1
|
)
|
|
(198.1
|
)
|
|
(215.7
|
)
|
|||
Total
|
11,171.3
|
|
|
9,414.1
|
|
|
8,188.5
|
|
|||
Medical benefits paid related to:
|
|
|
|
|
|
||||||
Current year
|
(10,081.7
|
)
|
|
(8,417.4
|
)
|
|
(7,431.4
|
)
|
|||
Prior years
|
(934.0
|
)
|
|
(759.3
|
)
|
|
(698.8
|
)
|
|||
Total
|
(11,015.7
|
)
|
|
(9,176.7
|
)
|
|
(8,130.2
|
)
|
|||
Ending balance
|
$
|
2,012.8
|
|
|
$
|
1,373.2
|
|
|
$
|
1,135.8
|
|
|
|
|
|
|
|
Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
|
As of December 31, 2018
|
||||||||||||
|
|
Incurred amount
|
|
Total of IBNR Liabilities Plus Expected Development on Reported Claims
|
|
Cumulative Number of Reported Claims
|
||||||||
Incurred Year
|
|
2017
|
|
2018
|
|
|
||||||||
2017
(1)
|
|
$
|
11,814.1
|
|
|
$
|
11,608.2
|
|
|
$
|
90.8
|
|
|
94.2
|
2018
(1)
|
|
|
|
13,163.3
|
|
|
1,836.9
|
|
|
101.6
|
||||
|
|
Total
|
|
|
$
|
24,771.5
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
For the years ended December 31,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
|
(in millions)
|
||||||||||
Beginning balance
|
$
|
722.5
|
|
|
$
|
510.0
|
|
|
$
|
473.9
|
|
Acquisitions
|
47.7
|
|
|
128.1
|
|
|
—
|
|
|||
Medical benefits incurred related to:
|
|
|
|
|
|
||||||
Current year
|
5,478.2
|
|
|
4,676.8
|
|
|
3,332.9
|
|
|||
Prior years
|
(130.4
|
)
|
|
(99.5
|
)
|
|
(54.4
|
)
|
|||
Total
|
5,347.8
|
|
|
4,577.3
|
|
|
3,278.5
|
|
|||
Medical benefits paid related to:
|
|
|
|
|
|
||||||
Current year
|
(4,780.9
|
)
|
|
(4,164.6
|
)
|
|
(2,901.3
|
)
|
|||
Prior years
|
(513.6
|
)
|
|
(328.3
|
)
|
|
(341.1
|
)
|
|||
Total
|
(5,294.5
|
)
|
|
(4,492.9
|
)
|
|
(3,242.4
|
)
|
|||
Ending balance
|
$
|
823.5
|
|
|
$
|
722.5
|
|
|
$
|
510.0
|
|
|
|
|
|
|
|
Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
|
As of December 31, 2018
|
||||||||||||
|
|
Incurred amount
|
|
Total of IBNR Liabilities Plus Expected Development on Reported Claims
|
|
Cumulative Number of Reported Claims
|
||||||||
Incurred Year
|
|
2017
|
|
2018
|
|
|
|
|
||||||
2017
|
|
$
|
5,583.3
|
|
|
$
|
5,457.4
|
|
|
$
|
31.3
|
|
|
32.3
|
2018
|
|
|
|
5,603.5
|
|
|
742.3
|
|
|
34.0
|
||||
|
|
Total
|
|
|
$
|
11,060.9
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
For the years ended December 31,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
|
(in millions)
|
||||||||||
Beginning balance
|
$
|
50.6
|
|
|
$
|
44.7
|
|
|
$
|
21.9
|
|
Acquisitions
|
—
|
|
|
—
|
|
|
—
|
|
|||
Medical benefits incurred related to:
|
|
|
|
|
|
||||||
Current year
|
666.6
|
|
|
823.4
|
|
|
637.0
|
|
|||
Prior years
|
(61.9
|
)
|
|
(70.0
|
)
|
|
(14.6
|
)
|
|||
Total
|
604.7
|
|
|
753.4
|
|
|
622.4
|
|
|||
Medical benefits paid related to:
|
|
|
|
|
|
||||||
Current year
|
(618.7
|
)
|
|
(773.9
|
)
|
|
(592.3
|
)
|
|||
Prior years
|
22.5
|
|
|
26.4
|
|
|
(7.3
|
)
|
|||
Total
|
(596.2
|
)
|
|
(747.5
|
)
|
|
(599.6
|
)
|
|||
Ending balance
|
$
|
59.1
|
|
|
$
|
50.6
|
|
|
$
|
44.7
|
|
|
|
|
|
|
|
Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
|
As of December 31, 2018
|
||||||||||||
|
|
Incurred amount
|
|
Total of IBNR Liabilities Plus Expected Development on Reported Claims
|
|
Cumulative Number of Reported Claims
|
||||||||
Incurred Year
|
|
2017
|
|
2018
|
|
|
||||||||
2017
|
|
$
|
823.4
|
|
|
$
|
753.2
|
|
|
$
|
—
|
|
|
51.3
|
2018
|
|
|
|
666.6
|
|
|
47.8
|
|
|
47.7
|
||||
|
|
Total
|
|
|
$
|
1,419.8
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
|
As of December 31, 2018
|
|||||||||||||
|
|
Incurred amount
|
|
Total of IBNR Liabilities Plus Expected Development on Reported Claims
|
|
Cumulative Number of Reported Claims
|
|||||||||
Incurred Year
|
|
2017
|
|
2018
|
|
|
|||||||||
2017
(1)
|
|
$
|
18,231.2
|
|
|
$
|
17,828.5
|
|
|
$
|
122.1
|
|
|
177.9
|
|
2018
(1)
|
|
|
|
19,440.6
|
|
|
2,629
|
|
|
183.4
|
|
||||
|
|
Total
|
|
|
$
|
37,269.1
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
Minimum Lease Payments
|
||
2019
|
$
|
42.4
|
|
2020
|
44.4
|
|
|
2021
|
45.5
|
|
|
2022
|
41.9
|
|
|
2023
|
38.7
|
|
|
2024 and thereafter
|
151.4
|
|
|
Total
|
$
|
364.3
|
|
|
|
|
For the Years Ended December 31,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
Current:
|
|
|
|
|
|
||||||
Federal
|
$
|
203.8
|
|
|
$
|
120.8
|
|
|
$
|
251.6
|
|
State
|
48.1
|
|
|
14.2
|
|
|
24.2
|
|
|||
|
251.9
|
|
|
135.0
|
|
|
275.8
|
|
|||
Deferred:
|
|
|
|
|
|
||||||
Federal
|
(0.3
|
)
|
|
(48.3
|
)
|
|
12.8
|
|
|||
State
|
1.4
|
|
|
1.2
|
|
|
(1.2
|
)
|
|||
|
1.1
|
|
|
(47.1
|
)
|
|
11.6
|
|
|||
Total income tax expense
|
$
|
253.0
|
|
|
$
|
87.9
|
|
|
$
|
287.4
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
Income tax expense at statutory federal rate
|
$
|
145.5
|
|
|
$
|
161.6
|
|
|
$
|
185.3
|
|
Adjustments resulting from:
|
|
|
|
|
|
||||||
State income tax, net of federal benefit
|
36.6
|
|
|
11.7
|
|
|
14.4
|
|
|||
Unrecognized tax benefits
|
2.5
|
|
|
(23.5
|
)
|
|
9.5
|
|
|||
Tax rate change
|
3.1
|
|
|
(56.1
|
)
|
|
—
|
|
|||
Non-deductible ACA industry fees
|
72.3
|
|
|
—
|
|
|
79.9
|
|
|||
Other, net
|
(7.0
|
)
|
|
(5.8
|
)
|
|
(1.7
|
)
|
|||
Total income tax expense
|
$
|
253.0
|
|
|
$
|
87.9
|
|
|
$
|
287.4
|
|
|
|
|
|
|
|
|
As of December 31,
|
||||||
Deferred tax assets:
|
2018
|
|
2017
|
||||
Net operating losses
|
$
|
31.6
|
|
|
$
|
24.7
|
|
Foreign tax credits
|
17.1
|
|
|
22.0
|
|
||
Medical and other benefits discounting
|
17.9
|
|
|
18.7
|
|
||
Allowance for doubtful accounts
|
30.4
|
|
|
14.8
|
|
||
Stock-based compensation
|
17.2
|
|
|
14.1
|
|
||
Unearned premium discounting
|
0.1
|
|
|
3.1
|
|
||
Capital losses
|
7.1
|
|
|
9.9
|
|
||
Premium deficiency reserve
|
3.9
|
|
|
10.7
|
|
||
Accrued expenses and other
|
19.4
|
|
|
5.6
|
|
||
Total deferred tax assets
|
144.7
|
|
|
123.6
|
|
||
Valuation allowance
|
(39.7
|
)
|
|
(48.5
|
)
|
||
Net deferred tax assets
|
105.0
|
|
|
75.1
|
|
||
Deferred tax liabilities:
|
|
|
|
||||
Goodwill and other intangible assets
|
(150.5
|
)
|
|
(101.1
|
)
|
||
Software development costs and property and equipment
|
(77.2
|
)
|
|
(56.7
|
)
|
||
Prepaid assets
|
(11.5
|
)
|
|
(10.7
|
)
|
||
Total deferred tax liabilities
|
(239.2
|
)
|
|
(168.5
|
)
|
||
Net deferred tax liability
|
$
|
(134.2
|
)
|
|
$
|
(93.4
|
)
|
|
|
|
|
|
Years Ended December 31,
|
||||||
|
2018
|
|
2017
|
||||
Unrecognized tax benefits, beginning of period
|
$
|
3.5
|
|
|
$
|
23.5
|
|
Increases:
|
|
|
|
||||
Prior year tax positions
|
2.6
|
|
|
—
|
|
||
Current year tax positions
|
1.7
|
|
|
3.5
|
|
||
Decreases:
|
|
|
|
||||
Prior year tax positions
|
—
|
|
|
(23.5
|
)
|
||
Unrecognized tax benefits, end of period
|
$
|
7.8
|
|
|
$
|
3.5
|
|
|
|
|
|
|
RSUs
|
|
Weighted
Average Grant-Date Fair Value |
|||
Outstanding as of January 1, 2018
|
274,643
|
|
|
$
|
120.73
|
|
Granted
|
129,520
|
|
|
205.47
|
|
|
Vested
|
(130,736
|
)
|
|
114.18
|
|
|
Forfeited
|
(20,192
|
)
|
|
153.09
|
|
|
Outstanding as of December 31, 2018
|
253,235
|
|
|
$
|
164.88
|
|
|
|
|
|
|
PSUs
|
|
Weighted
Average Award-Issuance Fair Value |
|||
Outstanding as of January 1, 2018
|
552,618
|
|
|
$
|
118.64
|
|
Granted
|
256,679
|
|
|
199.26
|
|
|
Vested
|
(154,055
|
)
|
|
91.32
|
|
|
Forfeited and expired
|
(48,534
|
)
|
|
150.13
|
|
|
Outstanding as of December 31, 2018
|
606,708
|
|
|
$
|
149.16
|
|
|
|
|
|
|
MSUs
|
|
Weighted
Average Grant-Date Fair Value |
|||
Outstanding as of January 1, 2018
|
45,230
|
|
|
$
|
130.01
|
|
Granted
|
45,075
|
|
|
130.01
|
|
|
Vested
|
(90,150
|
)
|
|
130.01
|
|
|
Forfeited and expired
|
(155
|
)
|
|
130.38
|
|
|
Outstanding as of December 31, 2018
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
December 31, 2018
|
|
December 31, 2017
|
||||
|
|
(in millions)
|
||||||
Assets
|
|
|
|
|
||||
Cash and cash equivalents
|
|
$
|
0.1
|
|
|
$
|
1.3
|
|
Investments
|
|
42.8
|
|
|
46.5
|
|
||
Reinsurance recoverables
|
|
170.2
|
|
|
166.9
|
|
||
Other assets
|
|
0.5
|
|
|
0.5
|
|
||
Total Assets
|
|
$
|
213.6
|
|
|
$
|
215.2
|
|
|
|
|
|
|
||||
Liabilities
|
|
|
|
|
||||
Reserves and other policy liabilities
|
|
$
|
166.9
|
|
|
$
|
148.6
|
|
Other liabilities
|
|
46.7
|
|
|
66.6
|
|
||
Total liabilities
|
|
$
|
213.6
|
|
|
$
|
215.2
|
|
|
|
|
|
|
|
For the Three Month Periods Ended
|
||||||||||||||
|
March 31, 2018
|
|
June 30, 2018
|
|
September 30, 2018
|
|
December 31, 2018
|
||||||||
Total revenues
|
$
|
4,646.2
|
|
|
$
|
4,639.0
|
|
|
$
|
5,058.1
|
|
|
$
|
6,070.8
|
|
Gross margin
(1)
|
550.7
|
|
|
637.0
|
|
|
676.9
|
|
|
688.2
|
|
||||
Income from operations
|
161.2
|
|
|
233.9
|
|
|
208.6
|
|
|
94.6
|
|
||||
Income before income taxes
|
158.5
|
|
|
229.9
|
|
|
215.2
|
|
|
89.2
|
|
||||
Net income
|
101.7
|
|
|
151.6
|
|
|
130.6
|
|
|
55.9
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Net income per share - basic
(2)
|
$
|
2.28
|
|
|
$
|
3.39
|
|
|
$
|
2.74
|
|
|
$
|
1.12
|
|
Net income per share - diluted
(2)
|
2.25
|
|
|
3.35
|
|
|
2.70
|
|
|
1.11
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Period end membership
|
4,284,000
|
|
|
4,384,000
|
|
|
5,508,000
|
|
|
5,538,000
|
|
|
For the Three Month Periods Ended
|
||||||||||||||
|
March 31, 2017
|
|
June 30, 2017
|
|
September 30, 2017
|
|
December 31, 2017
|
||||||||
Total revenues
|
$
|
3,954.2
|
|
|
$
|
4,305.0
|
|
|
$
|
4,402.9
|
|
|
$
|
4,345.1
|
|
Gross margin
(1)
|
438.5
|
|
|
543.4
|
|
|
620.7
|
|
|
493.1
|
|
||||
Income (loss) from operations
|
103.2
|
|
|
141.9
|
|
|
211.9
|
|
|
12.0
|
|
||||
Income (loss) before income taxes
|
103.2
|
|
|
114.7
|
|
|
235.1
|
|
|
8.6
|
|
||||
Net (loss) income
|
67.3
|
|
|
74.1
|
|
|
171.6
|
|
|
60.7
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Net income per share - basic
(2)
|
$
|
1.52
|
|
|
$
|
1.67
|
|
|
$
|
3.86
|
|
|
$
|
1.36
|
|
Net income per share - diluted
(2)
|
1.50
|
|
|
1.65
|
|
|
3.82
|
|
|
1.34
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Period end membership
|
4,078,000
|
|
|
4,428,000
|
|
|
4,349,000
|
|
|
4,371,000
|
|
|
For the Years Ended December 31,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
Revenues:
|
|
|
|
|
|
||||||
Investment and other income
|
$
|
2.1
|
|
|
$
|
0.3
|
|
|
$
|
0.1
|
|
Total revenues
|
2.1
|
|
|
0.3
|
|
|
0.1
|
|
|||
Expenses:
|
|
|
|
|
|
|
|
|
|||
Selling, general and administrative
|
82.6
|
|
|
63.4
|
|
|
37.5
|
|
|||
Interest expense
|
87.5
|
|
|
68.5
|
|
|
59.1
|
|
|||
Total expenses
|
170.1
|
|
|
131.9
|
|
|
96.6
|
|
|||
Loss from operations
|
(168.0
|
)
|
|
(131.6
|
)
|
|
(96.5
|
)
|
|||
Loss on extinguishment of debt
|
—
|
|
|
26.1
|
|
|
—
|
|
|||
Loss before income taxes
|
(168.0
|
)
|
|
(157.7
|
)
|
|
(96.5
|
)
|
|||
Income tax benefit
|
28.4
|
|
|
69.7
|
|
|
30.8
|
|
|||
Loss before equity in subsidiaries
|
(139.6
|
)
|
|
(88.0
|
)
|
|
(65.7
|
)
|
|||
Equity in earnings of subsidiaries
|
579.4
|
|
|
461.7
|
|
|
307.8
|
|
|||
Net income
|
439.8
|
|
|
373.7
|
|
|
242.1
|
|
|||
Other comprehensive (loss) income, before tax:
|
|
|
|
|
|
||||||
Change in net unrealized gains and losses on available-for-sale securities
|
(9.1
|
)
|
|
(2.2
|
)
|
|
1.8
|
|
|||
Income tax (benefit) expense related to other comprehensive income
|
(2.9
|
)
|
|
(0.5
|
)
|
|
0.6
|
|
|||
Other comprehensive (loss) income, net of tax
|
(6.2
|
)
|
|
(1.7
|
)
|
|
1.2
|
|
|||
Comprehensive income
|
$
|
433.6
|
|
|
$
|
372.0
|
|
|
$
|
243.3
|
|
|
As of December 31,
|
||||||
|
2018
|
|
2017
|
||||
Assets
|
|
|
|
||||
Current assets:
|
|
|
|
|
|||
Cash and cash equivalents
|
$
|
27.9
|
|
|
$
|
31.8
|
|
Short-term investments
|
—
|
|
|
2.1
|
|
||
Taxes receivable
|
—
|
|
|
16.4
|
|
||
Affiliate receivables and other current assets
|
3,273.7
|
|
|
1,050.3
|
|
||
Total current assets
|
3,301.6
|
|
|
1,100.6
|
|
||
Other asset
|
9.6
|
|
|
5.4
|
|
||
Investment in subsidiaries
|
3,089.5
|
|
|
2,509.6
|
|
||
Total Assets
|
$
|
6,400.7
|
|
|
$
|
3,615.6
|
|
|
|
|
|
||||
Liabilities and Stockholders' Equity
|
|
|
|
|
|
||
Current liabilities:
|
|
|
|
||||
Accrued expenses and other current liabilities
|
$
|
34.3
|
|
|
$
|
16.5
|
|
Total current liabilities
|
34.3
|
|
|
16.5
|
|
||
Long-term debt
|
2,126.4
|
|
|
1,182.4
|
|
||
Other liabilities
|
—
|
|
|
—
|
|
||
Total liabilities
|
2,160.7
|
|
|
1,198.9
|
|
||
|
|
|
|
||||
Commitments and contingencies (see Note 13)
|
—
|
|
|
—
|
|
||
|
|
|
|
||||
Stockholders' Equity:
|
|
|
|
|
|
||
Preferred stock, $0.01 par value (20,000,000 authorized, no shares issued or outstanding)
|
—
|
|
|
—
|
|
||
Common stock, $0.01 par value (100,000,000 authorized, 49,993,219 and 44,522,988 shares issued and outstanding at December 31, 2018 and December 31, 2017, respectively)
|
0.5
|
|
|
0.4
|
|
||
Paid-in capital
|
1,981.1
|
|
|
591.5
|
|
||
Retained earnings
|
2,267.3
|
|
|
1,827.5
|
|
||
Accumulated other comprehensive loss
|
(8.9
|
)
|
|
(2.7
|
)
|
||
Total stockholders' equity
|
4,240.0
|
|
|
2,416.7
|
|
||
Total Liabilities and Stockholders' Equity
|
$
|
6,400.7
|
|
|
$
|
3,615.6
|
|
|
For the Years Ended December 31,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
Net cash (used in) provided by operating activities
|
$
|
(30.1
|
)
|
|
$
|
(9.6
|
)
|
|
$
|
155.8
|
|
|
|
|
|
|
|
||||||
Cash used in investing activities:
|
|
|
|
|
|
|
|
||||
Net proceeds (payments) from purchases and sales and maturities of investments
|
(4.1
|
)
|
|
(1.6
|
)
|
|
1.2
|
|
|||
Payments to subsidiaries, net
|
(2,223.9
|
)
|
|
(99.7
|
)
|
|
(53.7
|
)
|
|||
Net cash used in investing activities
|
(2,228.0
|
)
|
|
(101.3
|
)
|
|
(52.5
|
)
|
|||
|
|
|
|
|
|
||||||
Cash provided by financing activities:
|
|
|
|
|
|
|
|
||||
Proceeds from issuance of common stock, net of issuance fees paid
|
1,342.3
|
|
|
—
|
|
|
—
|
|
|||
Proceeds from debt, net of financing costs paid
|
739.0
|
|
|
1,182.2
|
|
|
196.9
|
|
|||
Borrowings on Revolving Credit Facility, net of financing costs paid
|
221.3
|
|
|
—
|
|
|
—
|
|
|||
Payments on debt
|
(25.0
|
)
|
|
(1,026.1
|
)
|
|
(400.0
|
)
|
|||
Repurchase and retirement of shares to satisfy tax withholding requirements
|
(23.4
|
)
|
|
(15.2
|
)
|
|
(7.0
|
)
|
|||
Net cash provided by (used in) financing activities
|
2,254.2
|
|
|
140.9
|
|
|
(210.1
|
)
|
|||
|
|
|
|
|
|
||||||
Cash and cash equivalents:
|
|
|
|
|
|
|
|
|
|||
(Decrease) increase in cash and cash equivalents
|
(3.9
|
)
|
|
30.0
|
|
|
(106.8
|
)
|
|||
Balance at beginning of period
|
31.8
|
|
|
1.8
|
|
|
108.6
|
|
|||
Balance at end of period
|
$
|
27.9
|
|
|
$
|
31.8
|
|
|
$
|
1.8
|
|
|
|
|
|
INCORPORATED BY REFERENCE
|
||||||
Exhibit
Number |
|
|
Description
|
|
Form
|
|
Filing Date
with SEC |
|
Exhibit
Number |
|
2.1
|
|
|
|
10-Q
|
|
July 31, 2018
|
|
2.1
|
||
3.1
|
|
|
|
10-K
|
|
February 12, 2016
|
|
3.1
|
||
3.2
|
|
|
|
8-K
|
|
November 2, 2010
|
|
3.2
|
||
4.1
|
|
|
|
10-Q
|
|
November 4, 2010
|
|
4.1
|
||
4.2
|
|
|
|
8-K
|
|
March 23, 2017
|
|
4.1
|
||
|
|
|
8-K
|
|
March 23, 2017
|
|
4.2
|
10.4
|
|
Non-Employee Director Compensation Policy
|
||||||||
|
|
|
|
10-K
|
|
February 13, 2018
|
|
10.4.b
|
||
|
|
|
10-Q
|
|
May 1, 2018
|
|
10.1
|
|||
|
|
|
||||||||
10.5
|
|
Forms of Indemnification Agreement
|
||||||||
|
|
a.
Adopted May 16, 2003
*
|
|
S-1/A
|
|
June 8, 2004
|
|
10.24
|
||
|
|
b.
Adopted May 8, 2009
*
|
|
8-K
|
|
May 14, 2009
|
|
10.1
|
||
|
|
|
10-Q
|
|
August 9, 2010
|
|
10.8
|
|||
|
||||||||||
Agreements with Individual Officers and Directors
|
||||||||||
10.6
|
|
|
8-K
|
|
January 27, 2014
|
|
10.1
|
|||
10.7
|
|
|
8-K
|
|
November 5, 2014
|
|
10.1
|
|||
|
|
|
|
|
|
|
|
|
||
MATERIAL OPERATIONAL AGREEMENTS
|
||||||||||
10.8
|
|
|
8-K
|
|
January 12, 2016
|
|
10.1
|
|||
|
|
|
8-K
|
|
March 23, 2017
|
|
10.1
|
|||
10.9
|
|
|
8-K
|
|
July 24, 2018
|
|
10.1
|
|||
21.1
|
|
|
|
|
|
|
|
|||
23.1
|
|
|
|
|
|
|
|
|||
31.1
|
|
|
|
|
|
|
|
|||
31.2
|
|
|
|
|
|
|
|
|||
32.1
|
|
|
|
|
|
|
|
|||
32.2
|
|
|
|
|
|
|
|
|||
101.INS
|
|
XBRL Instance Document ††
|
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document ††
|
|
|
|
|
|
|
||
101.CAL
|
|
XBRL Taxonomy Calculation Linkbase Document ††
|
|
|
|
|
|
|
||
101.DEF
|
|
XBRL Taxonomy Definition Linkbase Document ††
|
|
|
|
|
|
|
||
101.LAB
|
|
XBRL Taxonomy Labels Linkbase Document ††
|
|
|
|
|
|
|
||
101.PRE
|
|
XBRL Taxonomy Presentation Linkbase Document ††
|
|
|
|
|
|
|
*
|
Denotes a management contract or compensatory plan, contract or arrangement
|
†
|
Filed herewith
|
††
|
Furnished herewith and not filed for purposes of Section 11 and Section 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934
|
WellCare Health Plans, Inc.
|
|
By:
|
/s/ Kenneth A. Burdick
|
|
Kenneth A. Burdick
|
|
Chief Executive Officer
|
Signatures
|
|
Title
|
|
Date
|
/s/Kenneth A. Burdick
|
|
Chief Executive Officer (Principal Executive Officer and Director)
|
|
February 12, 2019
|
Kenneth A. Burdick
|
|
|
|
|
|
|
|
|
|
/s/Andrew L. Asher
|
|
Executive Vice President and Chief Financial Officer (Principal Financial Officer)
|
|
February 12, 2019
|
Andrew L. Asher
|
|
|
|
|
|
|
|
|
|
/s/Michael Troy Meyer
|
|
Vice President and Chief Accounting Officer
|
|
February 12, 2019
|
Michael Troy Meyer
|
|
|
|
|
|
|
|
|
|
/s/Christian P. Michalik
|
|
Chairman of the Board
|
|
February 12, 2019
|
Christian P. Michalik
|
|
|
|
|
|
|
|
|
|
/s/Richard C. Breon
|
|
Director
|
|
February 12, 2019
|
Richard C. Breon
|
|
|
|
|
|
|
|
|
|
/s/Amy Compton-Phillips
|
|
Director
|
|
February 12, 2019
|
Amy Compton-Phillips
|
|
|
|
|
|
|
|
|
|
/s/H. James Dallas
|
|
Director
|
|
February 12, 2019
|
H. James Dallas
|
|
|
|
|
|
|
|
|
|
/s/Kevin F. Hickey
|
|
Director
|
|
February 12, 2019
|
Kevin F. Hickey
|
|
|
|
|
|
|
|
|
|
/s/Piyush "Bobby" Jindal
|
|
Director
|
|
February 12, 2019
|
Piyush "Bobby" Jindal
|
|
|
|
|
|
|
|
|
|
/s/Glenn D. Steele, Jr.
|
|
Director
|
|
February 12, 2019
|
Glenn D. Steele, Jr.
|
|
|
|
|
|
|
|
|
|
/s/William L. Trubeck
|
|
Director
|
|
February 12, 2019
|
William L. Trubeck
|
|
|
|
|
|
|
|
|
|
/s/Kathleen E. Walsh
|
|
Director
|
|
February 12, 2019
|
Kathleen E. Walsh
|
|
|
|
|
|
|
|
|
|
/s/Paul E. Weaver
|
|
Director
|
|
February 12, 2019
|
Paul E. Weaver
|
|
|
|
|
1.
|
Purpose of the Plan
|
2.
|
Effective Date
|
3.
|
Administration
|
4.
|
Participation
|
5.
|
Severance Benefits
|
Tier as of Termination Date
|
Cash Severance
|
Health Benefit Continuation
|
Tier I Participant
|
1.5 x Base Salary
plus
1.5 x Bonus
|
18 months
|
Tier II Participant
|
1 x Base Salary
plus
1 x Bonus
|
12 months
|
Tier III Participant
|
1 x Base Salary
plus
1 x Bonus
|
12 months
|
Tier as of Termination Date
|
Cash Severance
|
Health Benefit Continuation
|
Tier I Participant
|
3 x Base Salary
plus
3 x Bonus
plus
1x Prorated Bonus
|
36 months
|
Tier II Participant
|
2 x Base Salary
plus
2 x Bonus
plus
1x Prorated Bonus
|
24 months
|
Tier III Participant
|
1.5 x Base Salary
plus
1.5 x Bonus
plus
1x Prorated Bonus
|
18 months
|
6.
|
Other Terms and Conditions of Eligibility
|
7.
|
Benefit Claims
|
8.
|
Recoupment
|
9.
|
General
|
10.
|
Definitions
|
Entity Name
|
Jurisdiction of Organization
|
Accountable Care Coalition of Arizona, LLC
|
Arizona
|
Accountable Care Coalition of Central Georgia, LLC
|
Georgia
|
Accountable Care Coalition of Chesapeake, LLC
|
Maryland
|
Accountable Care Coalition of Coastal Georgia, LLC
|
Georgia
|
Accountable Care Coalition of Community Health Centers II, LLC
|
Texas
|
Accountable Care Coalition of Community Health Centers, LLC
|
Texas
|
Accountable Care Coalition of DeKalb, LLC
|
Georgia
|
Accountable Care Coalition of Georgia, LLC
|
Georgia
|
Accountable Care Coalition of Hawaii LLC
|
Hawaii
|
Accountable Care Coalition of Maryland Primary Care, LLC
|
Maryland
|
Accountable Care Coalition of Maryland, LLC
|
Maryland
|
Accountable Care Coalition of Mississippi, LLC
|
Mississippi
|
Accountable Care Coalition of Mount Kisco, LLC
|
New York
|
Accountable Care Coalition of New Jersey LLC
|
New Jersey
|
Accountable Care Coalition of North Texas, LLC
|
Texas
|
Accountable Care Coalition of Northeast Georgia, LLC
|
Georgia
|
Accountable Care Coalition of Northeast Partners, LLC
|
Pennsylvania
|
Accountable Care Coalition of Northwest Florida, LLC
|
Florida
|
Accountable Care Coalition of South Carolina, LLC
|
South Carolina
|
Accountable Care Coalition of Southeast Partners, LLC
|
Georgia
|
Accountable Care Coalition of Southeast Texas, Inc.
|
Texas
|
Accountable Care Coalition of Southeast Wisconsin, LLC
|
Wisconsin
|
Accountable Care Coalition of Syracuse, LLC
|
New York
|
Accountable Care Coalition of Tennessee, LLC
|
Tennessee
|
Accountable Care Coalition of Texas, Inc.
|
Texas
|
Accountable Care Coalition of the North West Region, LLC
|
Oregon
|
Accountable Care Coalition of the Northwest Region II, LLC
|
Oregon
|
Accountable Care Coalition of the Tri-Counties, LLC
|
South Carolina
|
Accountable Care Coalition of Western Georgia, LLC
|
Georgia
|
American Progressive Life and Health Insurance Company of New York
|
New York
|
America's 1st Choice California Holdings, LLC
|
Florida
|
APS Healthcare Holdings, Inc.
|
Delaware
|
APS Healthcare, Inc.
|
Delaware
|
APS Parent, Inc.
|
Delaware
|
AWC of Syracuse, Inc.
|
New York
|
Entity Name
|
Jurisdiction of Organization
|
Caidan Holding Company
|
Michigan
|
Caidan Management Company, LLC
|
Michigan
|
Caidan Network Services, LLC
|
Michigan
|
Care 1st Health Plan Arizona, Inc.
|
Arizona
|
Care1st Health Plan Administrative Services, Inc.
|
Arizona
|
Chrysalis Medical Services, LLC
|
New Jersey
|
Collaborative Health Systems of Maryland, LLC
|
Maryland
|
Collaborative Health Systems of Virginia, LLC
|
Virginia
|
Collaborative Health Systems, LLC
|
New York
|
Comprehensive Health Management, Inc. (also does business as Comprehensive Health Management Inc. of Florida, Comprehensive Health Management of Florida, Inc., Florida Comprehensive Health Management, Inc., Comprehensive Health Management of Pennsylvania, Inc., and WellCare Innovation Institute)
|
Florida
|
Comprehensive Reinsurance, Ltd.
|
Cayman Islands
|
Easy Choice Health Plan, Inc.
|
California
|
Essential Care Partners, LLC
|
Texas
|
Exactus Pharmacy Solutions, Inc. (f/k/a WellCare Specialty Pharmacy, Inc.)
|
Delaware
|
Harmony Behavioral Health IPA, Inc.
|
New York
|
Harmony Behavioral Health, Inc.
|
Florida
|
Harmony Health Management, Inc.
|
New Jersey
|
Harmony Health Plan, Inc. (f/k/a Harmony Health Plan of Illinois, Inc.)
|
Illinois
|
Harmony Health Systems, Inc.
|
New Jersey
|
Heritage Health Systems of Texas, Inc.
|
Texas
|
Heritage Health Systems, Inc.
|
Texas
|
HHS Texas Management, Inc.
|
Georgia
|
HHS Texas Management, L.P.
|
Georgia
|
Hudson Accountable Care, LLC
|
New York
|
Maine Community Accountable Care Organization, LLC
|
Maine
|
Maine Primary Care Holdings, LLC
|
Maine
|
Maryland Collaborative Care Transformation Organization, Inc.
|
Delaware
|
Maryland Collaborative Care, LLC
|
Maryland
|
Meridian Health Plan of Illinois, Inc.
|
Illinois
|
Meridian Health Plan of Michigan, Inc.
|
Michigan
|
MeridianRx IPA, LLC
|
New York
|
MeridianRx, LLC
|
Michigan
|
Mid-Atlantic Collaborative Care, LLC
|
Maryland
|
Missouri Care, Incorporated (also does business as Missouri Care and Missouri Care Health Plan)
|
Missouri
|
Northern Maryland Collaborative Care, LLC
|
Maryland
|
Ohana Health Plan, Inc.
|
Hawaii
|
One Care by Care1st Health Plan of Arizona, Inc.
|
Arizona
|
Entity Name
|
Jurisdiction of Organization
|
Penn Marketing America, LLC
|
Delaware
|
Premier Marketing Group, LLC
|
Delaware
|
Quincy Coverage Corporation
|
New York
|
SelectCare Health Plans, Inc.
|
Texas
|
SelectCare of Texas, Inc.
|
Texas
|
The WellCare Management Group, Inc.
|
New York
|
UAM Agent Services Corp.
|
Iowa
|
UAM/APS Holding Corp.
|
Delaware
|
Universal American Corp.
|
Delaware
|
Universal American Financial Services, Inc.
|
Delaware
|
Universal American Holdings, LLC
|
Delaware
|
Virginia Collaborative Care, LLC
|
Virginia
|
WCG Health Management, Inc.
|
Delaware
|
WellCare Associate Assistance Fund, Inc.
|
Florida
|
WellCare Health Insurance Company of America
|
Arkansas
|
WellCare Health Insurance Company of Kentucky, Inc. (f/k/a WellCare Health Insurance of Illinois, Inc.; also does business as WellCare of Kentucky, Inc.)
|
Kentucky
|
WellCare Health Insurance Company of Louisiana, Inc.
|
Louisiana
|
WellCare Health Insurance Company of New Hampshire, Inc.
|
New Hampshire
|
WellCare Health Insurance Company of Washington, Inc.
|
Washington
|
WellCare Health Insurance Company of Wisconsin, Inc.
|
Wisconsin
|
WellCare Health Insurance of Arizona, Inc. (also does business as ‘Ohana Health Plan, Inc.)
|
Arizona
|
WellCare Health Insurance of Connecticut, Inc.
|
Connecticut
|
WellCare Health Insurance of New York, Inc.
|
New York
|
WellCare Health Insurance of North Carolina, Inc.
|
North Carolina
|
WellCare Health Insurance of Tennessee, Inc.
|
Tennessee
|
WellCare Health Plans New Jersey Voluntary Employee PAC Inc.
|
New Jersey
|
WellCare Health Plans of Arizona, Inc.
|
Arizona
|
WellCare Health Plans of California, Inc.
|
California
|
WellCare Health Plans of Kentucky, Inc.
|
Kentucky
|
WellCare Health Plans of New Jersey, Inc.
|
New Jersey
|
WellCare Health Plans of Tennessee, Inc.
|
Tennessee
|
WellCare Health Plans of Vermont, Inc.
|
Vermont
|
WellCare Health Plans of Wisconsin, Inc.
|
Wisconsin
|
WellCare Health Plans, Inc.
|
Delaware
|
WellCare National Health Insurance Company
|
Texas
|
WellCare of Alabama, Inc.
|
Alabama
|
WellCare of Arkansas, Inc.
|
Arkansas
|
WellCare of Connecticut, Inc.
|
Connecticut
|
Entity Name
|
Jurisdiction of Organization
|
WellCare of Florida, Inc. (also does business as Staywell Health Plan of Florida and HealthEase)
|
Florida
|
WellCare of Georgia, Inc.
|
Georgia
|
WellCare of Indiana, Inc.
|
Indiana
|
WellCare of Kansas, Inc.
|
Kansas
|
WellCare of Maine, Inc.
|
Maine
|
WellCare of Mississippi, Inc.
|
Mississippi
|
WellCare of Missouri Health Insurance Company, Inc.
|
Missouri
|
WellCare of Nebraska, Inc.
|
Nebraska
|
WellCare of New Hampshire, Inc.
|
New Hampshire
|
WellCare of New York, Inc.
|
New York
|
WellCare of North Carolina, Inc.
|
North Carolina
|
WellCare of Ohio, Inc.
|
Ohio
|
WellCare of Oklahoma, Inc.
|
Oklahoma
|
WellCare of Pennsylvania, Inc.
|
Pennsylvania
|
WellCare of Puerto Rico, Inc.
|
Puerto Rico
|
WellCare of South Carolina, Inc.
|
South Carolina
|
WellCare of Texas, Inc. (also does business as WellCare of Arizona)
|
Texas
|
WellCare of Virginia, Inc.
|
Virginia
|
WellCare of Washington, Inc.
|
Washington
|
WellCare Pharmacy Benefits Management, Inc.
|
Delaware
|
WellCare Prescription Insurance, Inc.
|
Florida
|
Windsor Health Group, Inc.
|
Tennessee
|
Worlco Management Services, Inc.
|
New York
|
1.
|
I have reviewed this Annual Report on Form 10-K of WellCare Health Plans, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date:
|
February 12, 2019
|
|
/s/ Kenneth A. Burdick
|
|
|
|
Kenneth A. Burdick
|
|
|
|
Chief Executive Officer
|
|
|
|
(Principal Executive Officer)
|
1.
|
I have reviewed this Annual Report on Form 10-K of WellCare Health Plans, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date:
|
February 12, 2019
|
|
/s/ Andrew L. Asher
|
|
|
|
Andrew L. Asher
|
|
|
|
Executive Vice President and Chief Financial Officer
|
|
|
|
(Principal Financial Officer)
|
|
|
EXHIBIT 32.1
|
(1)
|
The Form 10-K fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(2)
|
The information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date:
|
February 12, 2019
|
|
/s/ Kenneth A. Burdick
|
|
|
|
Kenneth A. Burdick
|
|
|
|
Chief Executive Officer
|
|
|
|
(Principal Executive Officer)
|
|
|
EXHIBIT 32.2
|
(1)
|
The Form 10-K fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(2)
|
The information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date:
|
February 12, 2019
|
|
/s/ Andrew L. Asher
|
|
|
|
Andrew L. Asher
|
|
|
|
Executive Vice President and Chief Financial Officer
|
|
|
|
(Principal Financial Officer)
|